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PrEP and Our Youth: IMPLICATIONS IN LAW AND
POLICY
Jason Potter Burda*
Abstract
Truvada®, an antiretroviral medication originally approved to treat human immunodeficiency virus (HIV), is the first drug to receive FDA approval for use by HIV-negative
individuals to actually prevent infection. The prophylactic use of an antiretroviral such as
Truvada is a pharmacological prevention method called “HIV pre-exposure prophylaxis”
(or “PrEP”). With an efficacy of over ninety percent when used as prescribed, Truvada as
PrEP has been embraced by the public health community, and implementation is under
way across the United States. Truvada as PrEP is currently indicated for adult use only,
but it may also be prescribed off-label to at-risk youth.
In this Article, I draw upon public health, neurodevelopmental, and psychosocial
research to argue that PrEP is a necessary tool in the fight against HIV among youth. Thus,
exploring the challenges of delivering PrEP to at-risk youth is essential. As a general rule,
states mandate the involvement of parental figures in the healthcare of minors. However,
recognizing that parental involvement in sensitive matters such as sexually transmitted
infection (STI) treatment is a barrier to reaching youth, legislators have crafted limited
exceptions to this rule. With the goal of locating inroads to confidential PrEP access
in these exceptions, I survey STI, emancipation, and emergency consent laws, develop
frameworks for navigating them, and suggest that STI laws offer the most promise of offering
confidential PrEP access. Further, I posit that providing PrEP at clinics receiving Title X
family planning funds, which must offer confidential services to youth, may be a national
means of achieving that end. Yet guaranteeing accessibility is only one piece of the delivery
puzzle; guaranteeing acceptability is a second. As such, I propose the addition of PrEP to
sexual education programming funded by grants from the ACA’s Personal Responsibility
Education Program, which would ensure that curricula include PrEP alongside more
established prevention methods such as condoms. Overcoming these barriers will pave
the way for rapid uptake of future HIV prevention innovations for and among the most
vulnerable: our youth.
Full-Time Lecturer, University of Massachusetts School of Law. The author would like to thank Daniel
Bruner, JD, MPP, Senior Director of Policy at Whitman-Walker Health; Paul G. Loberti, MPH, Administrator
for Medical Services, Rhode Island Medicaid Division; and Aaron David Burda.
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Introduction
Of the nearly 50,000 new HIV infections in the United States every year, the United
States Centers for Disease Control and Prevention (CDC) estimates that, as of 2013, over
twenty percent of those infections were among youth.1 That year, the CDC estimated that
62,400 youth had HIV in the United States, and over half of those youth (n=32,000) were
living with an undiagnosed infection.2 These data reveal that the HIV crisis among youth
is both significant and stealthy. Yet the obstacles to effective HIV prevention among youth
are growing. Temporally removed from the AIDS crisis and less fearful of HIV because
treatment has advanced so rapidly and so publicly, today’s youth are increasingly resistant
to traditional HIV prevention models rooted in behavioral modification, risk reduction, and
condom education. In short, youth in the United States are on a collision course with HIV,
and incorporating new, sustainable prevention modalities as part of a multifaceted HIV
prevention approach will be necessary to avoid greater impact.
HIV pre-exposure prophylaxis (PrEP) has proved a necessary tool in the at-risk adult
population, and implementation is underway on a broad scale. PrEP is a pharmacological
HIV prevention modality3 involving prescription of antiretroviral drugs (ARVs),
traditionally used to treat those living with HIV, to at-risk HIV-negative individuals to
avoid infection. The only ARV currently approved for a PrEP indication is a daily dose
of Truvada, manufactured exclusively by Gilead Sciences and available by prescription.4
1  HIV Among Youth, Ctrs. for Disease Control & Prevention, http://www.cdc.gov/hiv/group/age/youth
[http://perma.cc/3UBC-5V2L] (last visited June 30, 2015) (noting that, of the 47,352 people diagnosed during
2013, twenty-one percent (n=9,961) were youth ages thirteen through twenty-four). As of this writing, 2013
data is the most recent available pertaining to HIV among youth. For the purpose of data collection, the CDC
defines “youth” as young people between thirteen and twenty-four years of age.
2  See id.
3   Pharmacological prevention is one of several modalities under the broader umbrella of “biomedical
HIV prevention.” In this Article, biomedical HIV prevention includes: (1) pharmacological HIV prevention;
(2) over-the-counter barrier methods such as male and female condoms, dental dams, and diaphragms; and (3)
medical procedures such as male circumcision. See Jason Potter Burda, When Condoms Fail: Making Room
Under the ACA Blanket for PrEP HIV Prevention, 52 San Diego L. Rev. 171, 174 n.18, 176 n.28, 182 (2015),
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2489457 [http://perma.cc/2RQX-9LLS]; Kristen
Underhill, Paying for Prevention: Challenges to Health Insurance Coverage for Biomedical HIV Prevention
in the United States, 38 Am. J.L. & Med. 607, 610 (2012); Gita Ramjee & Claire Whitaker, Biomedical HIV
Prevention, in Biomedical Engineering - From Theory to Applications 23 (Reza Fazel-Rezai ed., 2011),
http://cdn.intechweb.org/pdfs/18622.pdf [http://perma.cc/4TLN-Y4Y7].
4  Pre-Exposure Prophylaxis (PrEP), AIDS.gov, https://www.aids.gov/hiv-aids-basics/prevention/reduceyour-risk/pre-exposure-prophylaxis [http://perma.cc/C6QQ-K4DP] (last updated Nov. 25, 2015).
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With an effectiveness of over ninety percent in the adult population when taken as
prescribed, PrEP has received widespread federal and state endorsements. There is some
indication that recent HIV prevention initiatives incorporating PrEP may be working to
curb infections among adults.5 However, given the significant rate of HIV infection among
youth, attention has begun to shift to operationalizing PrEP for those youth whose behavior
or circumstances puts them at high risk of contracting HIV (herein, “at risk” or “at-risk
youth”).
Experts are only beginning to understand the magnitude of the challenges facing
those seeking to deliver PrEP to youth,6 but the same base obstacles facing those seeking
wider implementation of PrEP among adults also face those seeking to operationalize
PrEP for youth. In my previous article, When Condoms Fail, I identified two hurdles to
implementation of PrEP among adults: accessibility and acceptability.7 PrEP must be
accessible to those most at risk of HIV infection. As such, the therapy must be “procurable
with little complication or delay.”8 Furthermore, PrEP must be acceptable to those who
stand to benefit from it. This involves eliminating the stigma that attaches to those who use
it. For youth, these challenges have added complexity and an unmistakably legal dimension.
Pursuant to laws in every United States jurisdiction, the majority of youth in the United
States from ages thirteen to eighteen, a critical population in the fight against HIV, are
unable to operate independently of their parents, guardians, and other adult caregivers9 in
most healthcare decisions. Parental involvement and consent, though appropriate in many
circumstances, can result in delays in care, breaches of confidentiality, and the eschewing
5  See, e.g., Liz Highleyman, San Francisco Sees Decline in New HIV Infections and Deaths of People with
HIV, HIV & Hepatitis (July 14, 2015), http://hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/5283san-francisco-sees-declines-in-new-hiv-infections-and-deaths-of-people-with-hiv-2 [http://perma.cc/KC84Y3LM].
6   As of this writing, two academic pieces exploring PrEP for youth have been published in medical and
public health journals. See Lindsay Culp & Lisa Caucci, State Adolescent Consent Laws and Implications for
HIV Pre-Exposure Prophylaxis, 44 Am. J. Preventive Med. 119 (2013); Quianta L. Moore et al., Legal Barriers
to Adolescent Participation in Research About HIV and Other Sexually Transmitted Diseases, 106 Am. J. Pub.
Health 40 (2016).
7  See Burda, supra note 3, at 192–214.
8  See id. at 193.
9   In this Article, the terms “adult caregiver,” “parent,” and “guardian” describe an adult charged with legal
decision-making capacity for a minor; these terms should be interpreted as including, as the case may be, nonparent adults such as blood and non-blood related relatives, foster parents, conservators, and the state.
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of care entirely in the context of sexual healthcare. For example, approximately half of
all female adolescents would prefer to forego sexual healthcare services than permit their
providers10 to notify a parent of their decision to take birth control.11 Moreover, youth whose
circumstances put them at risk of HIV infection—such as detained youth, homeless or
unstably housed youth, young men who have sex with men, serodiscordant youth couples,
and youth who share syringes—tend to eschew healthcare at a higher rate than average.12
Thus, in the area of HIV prevention advocacy and policy, developing sustainable solutions to
reach at-risk youth without compromising their privacy has become a priority. Developing
such solutions will require not just clever public health advocacy and policymaking, but
also clever lawyering and lawmaking.
In this Article, I study PrEP as a vehicle for exploring the major challenges to
operationalizing pharmacological HIV prevention for at-risk youth. In Part I, I review
adolescent13 psychosocial and neurodevelopmental science to argue that traditional
models of HIV prevention, without the incorporation of new, sustainable solutions, have
a high likelihood of failure among the youth population and have, in fact, failed to curb
HIV incidence among youth. As such, PrEP is a much-needed addition to the youth HIV
prevention toolbox. In Part II, I focus on the accessibility challenge of operationalizing
PrEP for youth presented by parental consent and notification requirements, and review
state exceptions to the general rule that minors may not consent to their own healthcare. I
argue that the surest avenue to operationalizing PrEP for unaccompanied, self-consenting
minors without breaching confidentiality is by concentrating on STI consent laws at the
state level, for which I conduct a comprehensive survey, and on clinics receiving Title X
10   In this Article, the term “provider” describes an individual (such as a physician or advanced practice
nurse) or entity (such as a health center or clinic) furnishing healthcare services.
11  
N. Labor et al., N.Y.C. Dep’t. of Health and Mental Hygiene, Healthy Teens Initiative: Seven Steps
to Comprehensive Sexual and Reproductive Health Care for Adolescents in New York City 1 (2006),
http://www.nyc.gov/html/doh/downloads/pdf/ms/ms-hti-guide.pdf [http://perma.cc/9BM3-HPAH] (citing U.S.
Dep’t of Health & Hum. Servs., Healthy People 2010: Understanding and Improving Health and Objectives
for Improving Health (2d ed. 2000)).
12  
See Paul Arshagouni, But I’m an Adult Now . . . Sort Of: Adolescent Consent in Health Care DecisionMaking and the Adolescent Brain, 9 J. Health Care L. & Pol’y 315, 322 (2006) (citing Carol A. Ford et al.,
Foregone Health Care Among Adolescents, 282 JAMA 2227, 2230 tbl.2, 2231 (1999)).
13   In this Article, I do not use the terms “adolescent,” “minor,” and “youth” interchangeably. I use the term
“adolescent” in the context of neurodevelopmental, psychosocial, or other research focusing on the period of
adolescence, principally in Part I. I use the term “minor” in the context of state minor consent and parental
notification laws, principally in Part II, to reference individuals under the age of majority howsoever defined by
state law. I use the term “youth” at all other times to reference those individuals less than eighteen years of age.
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funding, at the federal level. In Part III, I focus on the acceptability challenge. I argue that
local, state, and federal governments play a role in ensuring that sexual education curricula
address the complete spectrum of available HIV prevention methods—including PrEP—so
that, in their providers’ offices, at-risk minors are familiar with PrEP therapy, view it as a
legitimate prevention modality, and have the knowledge to make reasoned decisions about
which prevention options work for them.
I. The Necessity of PrEP
“If there is anything that can be safely said about what is new in the
minds of adolescents, it is that they . . . have sex on their minds.”
—Carol Gilligan and Lawrence Kohlberg14
Adolescence, life’s second stage marked by the onset of puberty,15 is a “transitional
social category,”16 a time of significant physiological, neurological, and psychosocial
development.17 Alongside the physical maturation of secondary sex characteristics,
adolescents experience increased “neurological plasticity,” where the mind develops
increased cognitive abilities. Adolescence is also marked by vigorous behavioral changes,18
including an increase in awareness of—indeed, fixation on—peer relationships, and in
particular the sexual aspect of those relationships.19 At the same time, adolescents grow
14   Lawrence Kohlberg & Carol Gilligan, The Adolescent as a Philosopher: The Discovery of the Self in
a Post-Conventional World, in Twelve to Sixteen: Early Adolescence 1051, 1060 (Jerome Kagan & Robert
Coles eds., 1972). See also Linda Patia Spear, The Behavioral Neuroscience of Adolescence 3 (2010)
(noting that “[a]dolescence is a time of transitions: from childhood to adulthood, from dependence to (relative)
independence, from a nonsexual state to sexual maturity”).
15  See Jennifer Ann Drobac, “Developing Capacity”: Adolescent “Consent” at Work, at Law, and in the
Science of the Mind, 10 U.C. Davis J. Juv. L. & Pol’y 1, 11 (2004); Arshagouni, supra note 12, at 318. See also
Spear, supra note 14, at 5 (noting that adolescence, “the entire transition from childhood to adulthood,” and
puberty, “the more restricted time interval associated with the hormonal and physiological changes of sexual
maturation,” are distinct terms that should not be used synonymously).
16  Nicole Vitellone, Object Matters: Condoms, Adolescence and Time 13 (2008).
17  See Jennifer Ann Drobac, A Bee Line in the Wrong Direction: Science, Teenagers, and the Sting to “The
Age of Consent,” 20 J.L. & Pol’y 63, 66 (2011) (citing Spear, supra note 14, at 5).
18   Jay N. Giedd, The Digital Revolution and Adolescent Brain Development, 51 J. Adolescent Health 101
(2012).
19   Roxanne Mykitiuk et al., Legal Dimensions of Adolescent Sexuality, 26 J. Obstetrics & Gynaecology

Columbia Journal of Gender and Law

300

30.2

more removed from parents and other authority figures.20 At its crux, adolescence is a drive
toward autonomy replete with personal and inter-personal growth.21
This drive toward autonomy during adolescence can engender life-threatening
consequences.22 Mortality rates drastically increase during adolescence,23 and the behavior
causally related to this mortality increase is risk-taking.24 Concentrating primarily on
adolescent sexual risk-taking, the most concerning period for such behavior is midadolescence, specifically between the ages of fifteen and seventeen.25 This age span is an
especially important time for preventive sexual healthcare and harm reduction. According
to Dr. Laurence Steinberg:
[R]eward sensitivity, preference for immediate rewards, sensationseeking, and a greater focus on the rewards of a risky choice all increase
991 (2004).
20  Giedd, supra note 18, at 101.
21  Lisa J. Crockett & Ann C. Crouter, Pathways Through Adolescence: Individual Development
Relation to Social Contexts 2 (1995).

in

22 See generally D. Baumrind, A Developmental Perspective on Adolescent Risk Taking in Contemporary
America, in Handbook of Adolescent Social Behavior and Health 98 (Ralph J. DiClemente et al. eds., 1987)
(observing that, “[b]y definition, a transition period such as adolescence is disequilibrating and disrupting and
thus replete with opportunities that are both dangerous and growth enhancing”). See also Spear, supra note
14, at 130.
23  Charles E. Irwin & Susan G. Millstein, Risk-Taking Behaviors and Biopsychososcial Development
During Adolescence, in Emotion, Cognition, Health, and Development in Children and Adolescents 75,
76–77 (Elizabeth J. Susman et al. eds., 2014).
24  Id. In studies of adolescent risk-taking, researchers have characterized the following behaviors as risktaking activities: criminal activity, self-harm, thrill sports, sexual activity, and illicit drug use. See id. at 76. This
Article focuses on the major behavioral risk-taking activities attendant to HIV infection among adolescents:
sexual activity and, to a lesser extent as it is relevant within the Article, illicit drug use (particularly injection
drug use).
25   Laurence Steinberg, A Social Neuroscience Perspective on Adolescent Risk-Taking, 28 Developmental
Rev. 78 (2008), http://www.sciencedirect.com/science/article/pii/S0273229707000536 [http://perma.cc/494V69UG] [hereinafter Steinberg, Neuroscience Perspective]. It is generally understood that there are three stages
of adolescent social and psychosocial development: pre-adolescence, mid-adolescence, and emerging or young
adulthood. Bret J. Rudy, Adolescents and HIV, in Textbook of Pediatric HIV Care 197, 198 (Steven L.
Zeichner & Jennifer S. Read eds., 2005). The first stage, early adolescence, is roughly from ages twelve through
fourteen. See id. The second stage, or mid-adolescence, is roughly between the ages of fifteen and seventeen.
See id. The final stage, or late adolescence, is roughly between ages eighteen and nineteen. See id.
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between pre-adolescence and mid-adolescence, peak between ages 15 and
17, and then decline. In contrast, controlling impulses, planning ahead,
and resisting peer influence all increase gradually from pre-adolescence
through late adolescence, and in some instances, into early adulthood.26
As such, my primary focus in this Article is the period of mid-adolescence, a time of
unavoidable propensity for HIV-associated risk behaviors.
In this section, I review the science of adolescent development to argue that normative,
biologically driven increases in adolescent risk-taking, sensation-seeking, and peer
affiliation demonstrate the need to develop an HIV prevention safety net, and to clear the
social and legal barriers to delivery. I then argue that traditional methods of HIV prevention
among youth have been, and are likely to continue to be, ineffective without the addition
of a pharmacological HIV prevention safety net.
A. The Science of Adolescent Risk
During adolescence, there is a conflict between sensation-seeking and an adolescent’s
ability to regulate his or her own behavior.27 Dr. Laurence Steinberg notes that, as a result
of brain maturation during adolescence, “changes . . . in the brain’s socio-emotional system
lead[] to increased reward-seeking, especially in the presence of peers, fueled mainly by
a dramatic remodeling of the brain’s dopaminergic system.”28 During this time, the desire
for novelty and sensation seeking increases “dramatically,” yet an adolescent’s ability to
“turn off” those impulses is not yet fully developed.29 It is only in adulthood that risk-taking
then tends to decline.30 According to Dr. Steinberg, these changes “make mid-adolescence
a time of heightened vulnerability to risky and reckless behavior.”31 Importantly, Steinberg
26   Laurence Steinberg, Should the Science of Adolescent Brain Development Inform Public Policy?, 28:3
Issues in Sci. & Tech. (2012), http://issues.org/28-3/Steinberg [http://perma.cc/U9XP-MXVV].
27
See Claudia Dreifus, Developmental Psychologist Says Teenagers Are Different: A Conversation with
Laurence Steinberg, N.Y. Times, Nov. 30, 2009, http://nyti.ms/1MGv1Qo [http://perma.cc/ZKY5-GY24].
28

Steinberg, Neuroscience Perspective, supra note 25, at 78.

29
Laurence Steinberg, Risk Taking in Adolescence: New Perspectives from Brain and Behavior Science,
16 Current Directions Psych. Sci. 55, 56 (2007) [hereinafter Steinberg, New Perspectives]; see also Dreifus,
supra note 27.
30

See Steinberg, New Perspectives, supra note 29, at 56.

31

Steinberg, Neuroscience Perspective, supra note 25, at 78.
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posits that the biologically-driven increase in risk-taking behavior in adolescence means
that modulating adolescent risk-taking is “unlikely to be remedied through educational
interventions designed to change adolescents’ perception, appraisal, or understanding of
risk.”32 In fact, scientists suggest that harm reduction strategies that insure against the
negative consequences of risk will be most effective in preventing those consequences
when risk-taking activity occurs.33 Examples of these strategies include oral contraception
to prevent pregnancy and the human papillomavirus (HPV) vaccine to prevent transmission
of the HPV.
Despite adolescent brain maturation that increases adolescent impulsivity and thrillseeking tendencies, adolescents do not lack the essential qualities that allow them to make
effective decisions about how to maximize their protection against certain important risks.
Steinberg posits that adolescents likely have the cognitive ability needed to make some
informed medical choices, especially when the decision requires adult consultation.34
Although there is not extensive data about adolescent decision-making in the medical
context,35 behavioral data related to adolescent risk generally has implications in the
context of adolescent harm reduction. For adolescents, “[s]uboptimal decisions typically
occur in tasks with immediate reward conditions.”36 In other words, in situations of
immediate pleasure, adolescents display an impaired ability to make reasoned decisions.37
In the context of harm reduction for adolescents, this suggests that, in conditions where an
adolescent is faced with a decision immediately prior to gratification—such as whether to
use a condom immediately before sex or whether to use a clean needle immediately before
32   Lawrence Steinberg, Risk Taking in Adolescence: What Changes, and Why?, 1021 Ann. N. Y. Acad.
Sci. 51 (2004), http://www.ncbi.nlm.nih.gov/pubmed/15251873 [http://perma.cc/LEE2-CEA6] [hereinafter
Steinberg, What Changes, and Why?]. See also Spear, supra note 14, at 154 (noting that “the emotional
context of the moment may favor reactive, ‘hot cognitions’ rather than decisions based on rational, logic-based
cognitive processing”).
33  See, e.g., Steinberg, What Changes, and Why?, supra note 32.
34  See Press Release, Am. Psychol. Assoc., While Adolescents May Reason as Well as Adults, Their
Emotional Maturity Lags, Says New Research, American Psychological Assoc. (Oct. 7, 2009), http://www.apa.
org/news/press/releases/2009/10/teen-maturity.aspx [http://perma.cc/NNZ2-9UVB].
35  See Irma M. Hein et al., Why Is It Hard to Make Progress in Assessing Children’s Decision-making
Competence?, 16 BMC Med. Ethics 1, 3 (2015), [http://perma.cc/65SG-Y5B2].
36  Theresa Teslovich et al., Adolescents Let Sufficient Evidence Accumulate Before Making a Decision
When Large Incentives Are at Stake, 17 Dev. Sci. 59, 60 (2014), https://www.simenlab.org/FinalPublications/
TeslovichEtAl_desc12092.pdf [https://perma.cc/WTA6-AQBL].
37  Id.
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injection—the adolescent is less capable of a reasoned decision. Stated another way, when
an adolescent separates the decision about protection from the act of sex or injection, and
instead makes harm reduction choices in the healthcare environment, the adolescent may
have a greater capacity to evaluate his or her susceptibility to HIV-associated risks and
rationally choose the prevention choices that work for him or her.
Against this backdrop, I examine HIV incidence among youth and traditional HIV
prevention models among youth and introduce PrEP, a new pharmacological prevention
method that comports with the foregoing scientific findings concerning adolescent risktaking and reward sensitivity.
B. Youth HIV Risk
Given adolescent predisposition to risk and impaired decision-making skills in risk
scenarios, it is unsurprising that youth account for a disproportionate amount of overall
HIV incidence in the United States.38 HIV affects a number of sub-populations of youth,
and many at-risk youth straddle risk categories.
Those especially prone to HIV infection are young gay, bisexual, transgender, and
questioning (GBTQ) youth, or using epidemiological terminology, those youth characterized as male who have sex with other youth characterized as male (YMSM).39 Of
the infections among young people, YMSM are “severely affected,”40 accounting for the
large majority of new infections.41 In 2010, according to the CDC, YMSM comprised

38  See Ctrs. for Disease Control & Prevention, Vital Signs: HIV Infection, Testing, and Risk Behaviors
Among Youths – United States, 61(47) Morbidity & Mortality Wkly. Rep’t 971, 971–96 (2012).
39  See id. For the purpose of this Article, the term YMSM includes any young man who has sex with another
man; this risk group includes those who self-identify as homosexual, heterosexual, bisexual, questioning,
and transgender. It is important to note that most HIV prevention studies aggregate YMSM and male-tofemale transgender groups. This, of course, is problematic because “transgender” is an umbrella term that
includes individuals who may identify as transgender, male, female, heterosexual, or homosexual, and does
not indicate anything about their sexual practices. Conversely, the term YMSM indicates a specific sexual
practice. Nonetheless, the CDC continues to aggregate the two groups for the purpose of data collection despite
increasing calls to treat these groups as distinct.
40   Brian C. Thoma & David M. Huebner, Parental Monitoring, Parent-Adolescent Communication About
Sex, and Sexual Risk Among Young Men Who Have Sex with Men, 18 AIDS & Behav. 1604, 1604 (2014),
http://link.springer.com/article/10.1007/s10461-014-0717-z [http://perma.cc/Q8ZC-QN3S].
41  See HIV Among Youth, supra note 1.
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approximately 19% of all new HIV infections and 72% of new infections among youth.42
This represented a 22% increase in infections from 2008 to 2010, making YMSM the
only risk group to show a substantial rise in new HIV infections during that period.43 The
CDC’s 2013 data—the most recent available as of this writing—is even more troubling.
In 2013, YMSM accounted for approximately 93% of all HIV infections among youth
ages thirteen to nineteen years old.44 Within the YMSM population, HIV incidence is
particularly concerning among African American YMSM ages thirteen through nineteen.45
In this sub-group, HIV incidence rose 50% from 2006 to 2009.46 These statistics illustrate
that developing effective HIV prevention programs to target YMSM generally, and African
American YMSM specifically, continues to be a challenge.
While most youth contract HIV as a result of activities attendant to sexual risk,47 youth
who inject drugs (IDU-youth) are also vulnerable to HIV infection if they share syringes.48
Among youth, and especially among street-involved youth, injection drug use is a rising
problem.49 Injection drug use also increases sexual risk behavior,50 which can also increase
42  Id.
43  Id. (n=7,200, n=8,800).
44  HIV Surveillance–Adolescents and Young Adults, Ctrs. for Disease Control & Prevention,
http://1.usa.gov/1Gjt1gz [http://perma.cc/D4DH-TG6D] (last visited May 19, 2015) [hereinafter CDC
Surveillance Slideshow]. In 2013, in the United States among young adult males ages thirteen through nineteen,
92.6% of infections (n=1,441) were attributed to MSM sexual contact, 1.4% of infections (n=21) were attributed
to injection drug use, 1.8% of infections (n=28) were attributed to both MSM sexual contact and injection drug
use, 3.3% of infections (n=51) were attributed to heterosexual sexual contact, and .9% of infections (n=15)
were attributed to other risk factors such as transfusions or prenatal exposure. Id. at 7.
45   The CDC estimates that, in 2010, African American youth represented 57% (n=7,000) of infections. See
HIV Among Youth, supra note 1. Hispanic and Caucasian youth each represented approximately twenty percent
of new infections among youth (20%, n=2,390; 20%, n=2,380). Id.
46  Rod McCullom, Lowering the Age for HIV Prevention, Atlantic, Feb. 11, 2015, http://theatln.tc/
1MnuHZy [http://perma.cc/7EMA-PK4T].
47  
See supra notes 41–44 and accompanying text.
48  
See Substance Abuse/Use, AIDS.gov, https://www.aids.gov/hiv-aids-basics/prevention/reduce-yourrisk/substance-abuse-use [https://perma.cc/6UAW-CC74] (last updated Jan. 14, 2014).
49  According to 2013 estimates by the U.S. Department of Health and Human Services (HHS), 28% of
participants in state-funded needle exchange programs in Massachusetts reported being under age twenty at
first injection. Massachusetts HIV/AIDS Data Fact Sheet: Injection Drug Users, Mass. Dep’t of Pub. Health
(Jan. 1, 2014), http://www.mass.gov/eohhs/docs/dph/aids/2014-profiles/idu.pdf [http://perma.cc/5LT5-96Y2].
50  See S. Chatterjee et al., Changes in the Prevalence of Injection Drug Use Among Adolescents and Young
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the risk of infection. As such, IDU-youth require specially tailored HIV prevention
modalities that help protect against both syringe-sharing and sexual risks.
Injection drug use among youth crosses the socio-economic spectrum, but is a significant
program among youth experiencing homelessness. In fact, homeless or unstably housed
youth are more likely to engage in a number of HIV risk behaviors, such as intercourse
without condoms, sharing syringes, sex in exchange for value, sex with an intravenous
drug user, and sex with a person living with HIV.51 Developing new, comprehensive HIV
prevention programs for homeless or unstably housed youth is especially important; in
the United States, homeless or unstably housed youth52 are two to ten times more likely to
contract HIV than adolescents who have stable housing.53
Another neglected population of youth especially prone to HIV infection is detained
youth. Detained youth often have multiple sexual partners.54 For example, in one study
analyzing HIV risk behaviors and STI history of 1,215 detained youth, 75% of the cohort
studied reported having three or more sexual partners, and 20% reported no condom use.55
Detained youth engaging in injection drug use are especially vulnerable to HIV infection if
sterile injection equipment is unavailable. Detained youth engaging in sexual and/or IDUrelated risk require comprehensive HIV prevention methods tailored to the harsh realities
of confinement.
Adults in Large U.S. Metropolitan Areas, 15 AIDS Behav. 1570, 1570–71 (2011), http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3299409/ [http://perma.cc/4734-9MMW]; HIV and Injection Drug Use in the United States,
Ctrs. for Disease Control & Prevention, http://www.cdc.gov/hiv/riskbehaviors/idu.html [http://perma.cc/
6QF5-TVQQ] (last updated Oct. 27, 2015).
51  HIV/AIDS Among Persons Experiencing Homelessness: Risk Factors, Predictors of Testing, and
Promising Testing Strategies, In Focus, Dec. 2012, at 1, http://www.nhchc.org/wp-content/uploads/2011/09/
InFocus_Dec2012.pdf [http://perma.cc/K944-8VHJ].
52   When I refer to “homeless youth” in this Article, I am referring to a broad spectrum of young people,
including runaway, unstably housed, castaway, unaccompanied, systems, and street youth.
53  See id.
54  See Matthew C. Aalsma et al., Mental Health Screening and STI Among Detained Youth, 36 J. Cmty.
Health 300 (2010).
55  R.J. Canterbury et al., Prevalence of HIV-Related Risk Behaviors and STDs Among Incarcerated
Adolescents, 17 J. Adolescent Health 173, 174–75 (1995), http://www.ncbi.nlm.nih.gov/pubmed/8519785
[http://perma.cc/YJM5-D2TG]. For additional statistics, see Linda A. Teplin, Major Mental Disorders,
Substance Use Disorders, Comorbidity, and HIV-AIDS Risk Behaviors in Juvenile Detainees, 56 Psychiatric
Servs. 823 (2005).
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While YMSM, IDU-youth, homeless youth, and detained youth are populations of
young people who face a significant risk of HIV infection, it is also important to highlight
another sub-population of youth who are also at significant risk of infection but have
been largely overlooked: the HIV-negative partner in a heterosexual, serodiscordant
youth couple. HIV-negative youth in serodiscordant (sometimes termed “serodifferent”)
relationships—that is, relationships in which one partner is living with HIV and the other
is not—will likely be a growing risk group in the future as a result of HIV normalization
and advances in HIV treatment. New prevention approaches will be needed when such
couples consider pregnancy, particularly in cases where an HIV-negative adolescent female
is seeking seeking pregnancy with a male living with HIV. At least one study in adults
established an association between heterosexual women living with HIV whose infection
was behaviorally acquired, and the desire for pregnancy.56 Finger and associates’ study
“suggested that [the desire for pregnancy] was associated with increased likelihood of . . .
condom-unprotected sex.”57 In developing HIV prevention programs targeting at-risk
youth, serodiscordant youth couples cannot be overlooked.
In the populations I have identified above, the potential health-related harms to these
youths, and to public health more generally, make examining our current HIV prevention
models for any gaps, and developing new and effective HIV prevention modalities to fill
those gaps, a necessity. To that end, in Part C, I review our predominant approach to HIV
prevention among youth, and in Part D, I introduce PrEP—a comprehensive prevention
strategy that protects at-risk youths against HIV regardless of the method of exposure or
the choices they may make.
C. Traditional HIV Prevention Methods for Youth
The predominant approach to HIV prevention among youth is education. Youths receive
information on sex and sexual health from a variety of sources, including friends, family,
school, non-profit organizations, and the media. Of these, the two most enduring day-today sources for most youths are schools and parents, guardians, and other adult caregivers.
In this section, I argue that access to complete and accurate information about HIV—or any
information about HIV at all—from these two sources is particularly problematic. First, I
argue that because sexual education programs vary across the country, information about
HIV prevention is inconsistent. Moreover, even in “comprehensive sex education” states
56   Julie J. Finger et al., Desire for Pregnancy and Risk Behavior in Young HIV-Positive Women, 26 AIDS
Patients Care & STDs 173, 174 (2012).
57  Id. at 173.
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that permit or require instruction about proper and consistent condom use, studies have
shown that youth are loath to use condoms. Second, HIV remains stigmatized, which could
cause at-risk youth who may already feel marginalized to forgo parental advice about sex
entirely. Thus, although these two informational strategies have proved effective in some
respects, they must be supplemented with a pharmacological prevention safety net to curb
the rise in HIV incidence among at-risk youth.
1. Access to Information about HIV Prevention
One of the enduring sexual risk prevention modalities for youth is educational programming in schools.58 This approach to educating youth on sex and sexual health, however,
varies on a jurisdictional basis, and the efficacy of each model of sexual education is
highly contested. The types of sexual education programming found in schools today are
variations on one of two themes: comprehensive and abstinence-only education.59 The
comprehensive approach includes discussion of abstinence, but also includes STI prevention
instruction about condom usage.60 One meta-analysis of eighty-three studies that measured
the effectiveness of comprehensive programming on HIV-related risk behavior found this
approach can have a positive impact on “delay[ing] or decreas[ing] sexual behaviors or
increas[ing] condom or contraceptive use.”61 On the other hand, traditional abstinence-only
education focuses on abstinence as the sole “morally correct” way to avoid contracting an
58  See generally Guttmacher Inst., In Brief: Fact Sheet – Facts on American Teens’ Sources of
Information About Sex (Feb. 2012), http://www.guttmacher.org/pubs/FB-Teen-Sex-Ed.html [http://perma.cc/
LS9S-GUL7] (summarizing the various sources of information about sex for youth in the United States).
59  See Nicole Vitellone, Object Matters: Condoms, Adolescence and Time 5 (2008). For a discussion of
the history of sex education programs, see id. at 13–35. For a complete side-by-side comparison of programs,
see Sex Education Programs: Definitions and Point-by-Point Comparison, Advocates for Youth (2001),
http://www.advocatesforyouth.org/publications/publications-a-z/655-sex-education-programs-definitionsand-point-by-point-comparison [http://perma.cc/5PKG-YJAN]. See also Kaiser Family Foundation, Sex
Education in America 45 (2000), https://kaiserfamilyfoundation.files.wordpress.com/2000/09/3048-sexeducation-in-america-a-view-from-inside-the-nations-classrooms.pdf [http://perma.cc/3RG9-Y7DS] (last
visited June 24, 2015) (comparing student perceptions after having enrolled in abstinence-only or comprehensive
sex-ed programs).
60  Siecus Fact Sheet, Sexuality Info. & Educ. Council of the United States (Oct. 2009), http://www.siecus.
org/index.cfm?fuseaction=Page.ViewPage&PageID=1193 [http://perma.cc/R8Y7-QSBS].
61  See D. Kirby, Sex and HIV Programs: Their Impact on Sexual Behaviors of Young People Throughout
the World, 40 J. Adolescent Health 206, 206–17 (2007) (referring to comprehensive programs as “curriculumbased”). See also Comprehensive Sex Education: Research and Results, Advocates for Youth (Sept. 2009),
http://www.advocatesforyouth.org/publications/1487 [http://perma.cc/V34D-FBXK] [hereinafter Research
and Results].
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STI or unwanted pregnancy, and may offer incomplete information about HIV prevention
or eliminate information about HIV entirely.62 No traditional abstinence-only program
that takes a moralistic approach has proven effective in decreasing STI infections among
youth.63
However, at the behest of state law- and policy-makers, school-based sex and HIV education is decidedly moralistic. A 2015 Guttmacher survey of state sex and HIV education
regulations, statutes, and “other legally binding policies” found that a majority of U.S. states
mandate that, when schools include sex and HIV education, information about abstinence
must be included.64 The survey also found that half of all United States states require that
educators “stress” abstinence,65 and that only a minority of states require that curricula is
“medically accurate.”66 Further, the survey found that only two states forbid the promotion
of religion, and eight states require unbiased instruction.67 Nonetheless, emphasis on
abstinence without giving adolescents complete and accurate information about reducing

62  See 3 Science and Success: Sex Education and Other Programs That Work to Prevent Teen Pregnancy,
HIV, and Sexually Transmitted Infections, Advocates For Youth (2012), http://www.advocatesforyouth.org/
storage/advfy/documents/thirdeditionexecutivesummary.pdf [http://perma.cc/GF4G-XLUP] (last visited July
3, 2015).
63  See Research and Results, supra note 61, at 2. There is some evidence that theory-based abstinenceonly programs—that is, programs that, unlike traditional abstinence-only programs, do not take a moralistic
approach to prevention—can be effective at delaying sexual involvement and reducing HIV-related behavioral
risks. See John B. Jemmott et al., Efficacy of a Theory-Based Abstinence-Only Intervention Over 24 Months: A
Randomized Controlled Trial with Young Adolescents, 164 Archives Pediatrics & Adolescent Med. 152, 157
(2010), http://nationalabstinenceclearinghouse.com/pdf/contentmgmt/abstinence.pdf [http://perma.cc/S48LQWDW]; Research and Results, supra note 61, at 10.
64  Guttmacher Inst., State Policies in Brief: Sex and HIV Education 2–3 (Dec. 1, 2015), http://www.
guttmacher.org/statecenter/spibs/spib_SE.pdf [http://perma.cc/T5KX-YM7P] [hereinafter Guttmacher State
Policies in Brief]. Only nineteen states require that sexuality education be “medically, factually, or technically”
accurate, though definitions of “medically accurate” are subject to variation. But see State Policies on Sex
Education in Schools, Nat’l Conf. on State Legislators, http://www.ncsl.org/research/health/state-policieson-sex-education-in-schools.aspx [http://perma.cc/TC4T-K2JN] (last updated Feb. 13, 2015) [hereinafter State
Policies on Sex Education].
65  See Guttmacher State Policies in Brief, supra note 64, at 2.
66  See id. at 1 (finding that thirteen states require that curricula be “medically accurate”). See also State
Policies on Sex Education, supra note 64 (placing the number of states that require sexuality education to be
“medically, factually or technically” accurate at nineteen and noting that definitions of “medically accurate”
are subject to variation).
67  Guttmacher State Policies in Brief, supra note 64, at 3.
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harm when risk behavior inevitably occurs68 will not likely be effective at reducing the
negative consequences of risky sexual behavior. This is especially true since the number of
students receiving HIV education in public schools has actually decreased in recent years,69
and data on effectiveness of education provided by community organizations is lacking.70
Apart from education in the public sphere, adult figures such as parents and guardians
are also an important source of information. A parental role in sexual education before the
youth’s first instance of sexual intercourse has been shown to increase condom use.71 In
one study, youth who talked with their mothers before their first sexual encounter were
three times more likely to use a condom when first having sex than those who never had
a discussion with a parent.72 However, the fact remains that many American youth feel
unable to discuss sexual healthcare with their parents or guardians,73 and for youth whose
behavior might be considered morally suspect, discussion of sexuality has the potential
to result in physical and emotional abuse.74 These threats become a barrier to receipt of
information about sexual health.
To illustrate, LGBTQ youth face “sexual orientation-specific stressors [of] ‘coming
68   KM Leslie, Can. Pediatric Ass’n, Harm Reduction: An Approach to Reducing Risky Health Behaviours
in Adolescents, 13 Pediatrics & Child Health 53, 54 (2008) (reaffirmed Feb. 1, 2014).
69   Of all fifty U.S. states, thirty-three require HIV education, see State Policies on Sex Education, supra
note 64, but the percentage of students who receive education on HIV has decreased from ninety-two percent
in 1997 to eighty-five percent in 2013. HIV Among Youth, supra note 1.
70   For a list of community organizations that promote and offer comprehensive sex education, see Organizations Working on Comprehensive Sex Education, Advocates For Youth, http://www.advocatesforyouth.org/
sercadv/1376?task=view [http://perma.cc/SA2W-K4F5] (listing religiously affiliated organizations). See also
Center: The Lesbian, Gay, Bisexual & Transgender Community Center, https://gaycenter.org/wellness/hivaids#hiv-and-aids-prevention-education [http://perma.cc/R5R7-SR25] (last visited July 3, 2015).
71  Patterns of Condom Use Among Adolescents, Ctrs. for Disease Control & Prevention (Oct. 1, 1998),
http://1.usa.gov/1J04Ipc [http://perma.cc/5J77-6PVG] [hereinafter Patterns of Condom Use].
72  Id.
73  See Press Release, Planned Parenthood, Half of Teens Feel Uncomfortable Talking With Parents (Oct.
2, 2012), http://www.plannedparenthood.org/about-us/newsroom/press-releases/half-all-teens-feel-uncomfo
rtable-talking-their-parents-about-sex-while-only-19-percent-parents [http://perma.cc/MH62-YSTZ].
74  See, e.g., Alex Morris, The Forsaken: A Rising Number of Homeless Gay Teens Are Being Cast Out by
Religious Families, Rolling Stone, Sept. 3, 2014, http://rol.st/1Bc3alO [http://perma.cc/X97E-YJLG]; Curtis
M. Wong, Jacqueline Alexander, Tennessee Mother, Allegedly Beat Son Because She Thought He Was “Too
Feminine” and Gay, Huffington Post, Feb. 20, 2015, http://huff.to/1M5EjHx [http://perma.cc/2ZS7-CTWG].
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out’ to parents,”75 victimization in school,76 and abuse at home. Because discussion of HIV
prevention between YMSM and parents can result in outing, embarrassment, violence,
and disownment, this makes receiving information concerning HIV at home particularly
difficult. But to make matters worse, Dr. Brian C. Thoma and associates noted in 2014 that
“[n]o effective intervention strategies have been developed to reduce HIV risk behaviors in
samples of . . . [Y]MSM with a mean age of less than [twenty-three].”77 In short, YMSM are
at a significant informational disadvantage with regard to HIV prevention compared to their
heterosexual counterparts. Not only may YMSM have difficulty receiving information about
HIV from schools and parents, but they may also have difficulty receiving information from
their government and from community organizations. These informational disadvantages
are paradigmatic of those facing other at-risk youth populations such as IDU-youth and
incarcerated youth, who by virtue of their marginalization may not have the same ability
as low-risk youth to prevent HIV. In this regard, developing effective HIV prevention
strategies for these at-risk youth is a public health and social justice imperative.
Nonetheless, even if at-risk youth have access to information about HIV prevention,
we must examine how that information is perceived, and balance our aspirations for youth
behavior with their realities. As I discuss in the next section, condom messaging, one of the
pillars of comprehensive sex and HIV education for youth, is problematic because condom
usage remains deeply unpopular among youth. This poses another barrier to effective HIV
prevention among at-risk youth.
2. Content of Information About HIV Prevention
“I HATE using condoms. I hate it. They almost dismiss the intimacy of
sex and make it more of a business exchange[,] [n]ot to mention feeling
not even half as good . . .”78
75   Thoma & Huebner, supra note 40, at 1605 (noting that “[p]arent-child dynamics change in important
ways when a child is gay or bisexual: family rejection is common, communication can be strained, and secrecy
looms in families where a child has not yet ‘come out’”).
76  See generally David M. Huebner et al., Abstract, School Victimization and Substance Use Among
Lesbian, Gay, Bisexual, and Transgender Adolescents, 16 Prevention Sci. 734, 734 (2015), http://link.springer.
com/article/10.1007/s11121-014-0507-x [http://perma.cc/5FEX-632T] (“Preventive interventions for LGBT
adolescents must not only attempt to make schools safer for these youth, but also help keep them engaged in
healthy peer groups when they are confronted with mistreatment in school.”).
77   Thoma & Huebner, supra note 40, at 1604.
78   Brian Mustanski et al., A Mixed-Methods Study of Condom Use and Decision Making Among Adolescent
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Condom education is considered “a critical and primary intervention strategy”79 to
curb youth STI infection and pregnancy, but it is clear that the strategy has failed to curb
HIV incidence in those youth most at risk of HIV infection. I have argued in a prior article
that, as evidenced by the troubling, continued rise in HIV infection among certain highrisk groups despite nearly thirty years of condom messaging, condoms have failed as
the primary HIV prevention modality in the United States among the adult population.80
Research also shows that the efficacy of condom messaging among at-risk youth is on the
decline. Indeed, condom use among youth under eighteen years of age has declined since
2003.81 In 1991, condom use among high school students was at 46%.82 Condom usage
peaked in 2003 at 63%.83 However, as of 2013, condom usage was down to 59%.84 In the
2013 National Youth Risk Behavior Survey by the CDC, of the 13,633 youth surveyed in
grades nine through twelve,85 41% of sexually active youth—34% of the youth population
surveyed—did not use a condom the last time they had intercourse.86 In a 2013 study of
African American YMSM, 67% of the cohort studied reported that they had unprotected
receptive anal intercourse in the previous six months.87
Gay and Bisexual Males, 18 AIDS & Behav. 1955, 1961 (2014) (quoting the perspective of an adolescent study
participant).
79  Id. at 1955–56.
80  Burda, supra note 3, at 172, 179–81.
81  
Ctrs. for Disease Control & Prevention, Sexual Risk Behaviors Among U.S. High School Students (July
2014), http://www.cdc.gov/nchhstp/newsroom/docs/factsheets/yrbs-fact-sheet-final-508.pdf [http://perma.cc/
PSH3-X8JM].
82  Child Trends Data Bank, Condom Use: Indicators on Children and Youth (July 2014), at 2, http://
www.childtrends.org/wp-content/uploads/2012/07/28_Condom_Use.pdf [http://perma.cc/N92H-NPW5].
83  Id.
84   Press Release, U.S. Ctrs. for Disease Control & Prevention, CDC Releases 2013 Youth Risk Behavior
(YRBS) Results (June 12, 2014), http://www.cdc.gov/Features/YRBS [http://perma.cc/S99L-S2WY].
85  Ctrs. for Disease Control & Prevention, Youth Risk Behavior Surveillance – United States, 2013,
Morbidity & Mortality Wkly. Rep., June 13, 2014, at 1, http://1.usa.gov/1sNLbC8 [http://perma.cc/2REX255Y].
86  
HIV and Other STD Prevention and United States Students, Ctrs. for Disease Control & Prevention,
http://www.cdc.gov/healthyyouth/yrbs/pdf/us_hiv_combo.pdf [http://perma.cc/EU4J-N69N] (last visited July
3, 2015).
87   Richard A. Crosby et al., Acceptability of Condoms, Circumcision and PrEP Among Young Black Men
Who Have Sex with Men: A Descriptive Study Based on Effectiveness and Cost, 2 Vaccines 129, 131 (2014),
http://www.mdpi.com/2076-393X/2/1/129/htm [http://perma.cc/98KG-TVFF]; see also Burda, supra note 3,
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One potential explanation for this decline in condom usage is youth attitudes towards
condoms. In a 2014 study of seventy-five fourteen to eighteen year-old gay and bisexual
males,88 Mustanski and associates found that, regarding youth attitudes about condom usage,
there were two recurring themes. First, among the cohort studied, the most common reasons
for not using condoms were that the availability of HIV and STI testing “can enable you to
know when a sex partner is ‘clean’” and when condom-less sex is appropriate.89 Second, as
expressed by one study participant, “many don’t like it because it doesn’t feel as good as
without a condom.”90 Regarding perceived pleasure decreases, even though approximately
61% of youth participants reported that condoms are “smart” to use or should be used, over
50% reported that the decrease in pleasure resulting from using condoms was the reason
to not use them.91 This suggests that youth perceptions that condoms are unnecessary (if
partners are frequently tested) and anesthetizing may help explain low usage rates.
Yet I propose a third reason that may cause negative youth attitudes about condoms:
messages to youth about the importance of practicing condom vigilance and their protective
benefit lack credibility. In fact, I have noted in a previous article that “condoms are medically
effective at preventing HIV, eliminating approximately 90–95% of the transmission risk
when used properly and vigilantly.”92 However, data concerning condom effectiveness
in practice indicate that the actual efficacy of condoms is likely around 60–70% due to
nonuse, intermittent use, and improper use.93 In the words of Dr. Janet Woodcock, Director
of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration,
the actual efficacy of condoms is likely “much lower, because many individuals do not
use them correctly or use them at all.”94 By extension, when one considers biological,
at 180.
88   Mustanski et al., supra note 78, at 1959–60.
89  Id. at 1961.
90  Id.
91  Id. at 1959.
92  Burda, supra note 3, at 179 (citing Steven D. Pinkerton & Paul R. Abramson, Effectiveness of Condoms in
Preventing HIV Transmission, 44 Soc. Sci. & Med. 1303, 1310 (1997)).
93  Id. at 179–80; Pinkerton & Abramson, supra note 92, at 1304 (citing Susan C. Weller, A Meta-Analysis
of Condom Effectiveness in Reducing Sexually Transmitted HIV, 36 Soc. Sci. & Med. 1635, 1640 (1993)). See
also U.S. Ctrs. for Disease Control & Prevention, HIV Surveillance Report: HIV Risk, Prevention, and
Testing Behaviors 8 (2011) (concluding that, “despite prevention efforts, a large proportion of MSM have sex
without using condoms and do not know their partner’s HIV status before having sex”).
94  See Letter from Janet Woodcock, Dir., Ctr. for Drug Evaluation & Res., to Tom Myers, Gen. Couns.,
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behavioral, and social influences on youth risk behavior, the rate of proper and consistent
condom usage among youth may be even lower than among adults. It is certainly possible
that youth are beginning to question the credibility of condom messaging since the rate
of intermittent, improper, and nonuse of condoms among youth (and the adults on whom
youth model their behavior) is so high.
What this reveals is that, to curb HIV infections among youth, advocates and policymakers must begin to rethink both HIV prevention content delivery, and the content itself.
Indeed, harm reduction strategies would probably be more productive at reducing HIV
incidence among youth than sex and HIV educational programs designed to teach risk
avoidance and behavioral modification.95
D. Pharmacological HIV Prevention and PrEP
Like oral contraception, which is a means to insure against the unintended consequences
of sexual intercourse, pharmacological HIV prevention is a means to insure youth against
the lifelong consequences of HIV-related risk.96
Pharmacological HIV prevention entails the prescription of pharmacologies by a
physician or advanced practice nurse for the purpose of preventing infection. Examples
of pharmacological HIV preventions include, but are not limited to: (a) oral, topical,
injectable, or implantable pre-exposure prophylaxis (“PrEP”) to prevent transmission in
the event of future exposure; (b) oral post-exposure prophylaxis (“PEP” or “nPEP”) taken
by HIV-negative individuals for a finite period after an actual exposure to HIV infection; (c)
“treatment as prevention” or “TasP,” which entails treatment of HIV-positive individuals
AIDS Healthcare Found., at 11 (July 16, 2012), http://1.usa.gov/1Ls2SPJ [http://perma.cc/4L6X-8T4P]
[hereinafter Letter from Janet Woodcock] (citing Pinkerton & Abramson, supra note 92, at 1306–07); Burda,
supra note 3, at 187.
95  See Steinberg, What Changes, and Why?, supra note 32, at 57. In his article, Dr. Steinberg notes that:
Rather than attempting to change the way adolescents evaluate risky activities (which
is, in essence, what health education programs attempt to do), a more profitable
strategy might focus on limiting opportunities for immature judgment to have harmful
consequences . . . . Strategies such as . . . expanding access to . . . contraceptive services
. . . would likely be more effective . . . than strategies aimed at making adolescents wiser,
less impulsive, or less short-sighted.
Id.
96  Id.
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with ARVs as a means of suppressing the HIV virus and preventing infection of others; and
(d) HIV vaccines.97 Of these, none has exploded onto the clinical research scene with the
same force that PrEP has.
The efficacy of PrEP in adults has been clearly established in numerous clinical trials,
observational studies, and post-trial analyses.98 Oral PrEP administered as a daily dose of
Truvada is effective at preventing HIV in adults, with an efficacy of above ninety percent
for those who take it consistently, and possibly higher.99 The CDC has stated that: “PrEP is
a powerful HIV prevention tool and can be combined with condoms and other prevention
methods to provide even greater protection than when used [without condoms].”100
In 2012, the FDA approved the combination of emtricitabine/tenofovir disoproxil
fumarate (TDF/FTC) marketed as Truvada under an exclusive patent by Gilead Sciences, for
daily dosage in pill form by at-risk, HIV-negative adults.101 The clinical profile of Truvada
for PrEP applications includes those individuals with partners living with HIV, as well as
those having sex in high prevalence social groups or who have partners of unknown HIV
status. In both of the latter cases, individuals should have at least one of the following risk
factors: (a) intermittent or no condom usage; (b) STI infection; (c) exchange of value for
sex; (d) illicit drug use; and/or (e) incarceration.102 In 2013, the United States Public Health
97  See Burda, supra note 3, at 182; Underhill, supra note 3, at 610.
98  Burda, supra note 3, at 182–87.
99  See id. at 184. See also Ctrs. for Disease Control & Prevention, Preexposure Prophylaxis for the
Prevention of HIV Infection in the United States–2014: A Clinical Practice Guideline 12–13 (2014),
http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf [http://perma.cc/2LV8-EJHC] [hereinafter CDC Guidelines]; PrEP: How Well Does PrEP Work?, U.S. Ctrs. for Disease Control & Prevention, http://www.cdc.gov/
hiv/basics/prep.html [http://perma.cc/K62V-EDR9] (last updated June 25, 2015). Recent studies have
shown that PrEP is up to ninety-nine percent effective when used daily. See, e.g., Peter L. Anderson et al.,
Embtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex
with Men, 4 Sci. Translational Med. 151ra125-1 (2012); What is the iPrEx Study?, iPrEx Ole, http://www.
iprexole.com/1pages/prep/prep-whatistheiprexstudy.php [http://perma.cc/P8WB-LJSW] (noting that the iPrEx
Ole study found that Truvada as PrEP provides “99% protection against HIV infection in MSM”).
100 Pre-exposure Prophylaxis (PrEP), U.S. Ctrs. for Disease Control & Prevention, http://www.cdc.gov/
hiv/prevention/research/prep [http://perma.cc/LDG7-F66P].
101 For an extensive discussion of the road to FDA approval of Truvada as PrEP, see Burda, supra note 3,
at 186–89.
102 Gilead Sciences, Inc., Truvada: Package Insert and Label Information, DrugInserts.Com, https://drug
inserts.com/lib/rx/meds/truvada-5 [https://perma.cc/PJ94-SHGC] (last revised Dec. 23, 2013). See also Burda,
supra note 3, at 188–89.
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Service (USPHS) issued clinical practice guidelines for adults, calling use of Truvada as
PrEP “safe and effective.”103 Indeed, there is a critical mass of research indicating that
the long-term side effects of PrEP in adults are minimal, though additional longitudinal
research is ongoing.104
However, PrEP is not merely a medication; it is a multi-dimensional, comprehensive
prevention strategy for at-risk individuals involving periodic testing, monitoring, and
supervision.105 The FDA has indicated that, prior to receiving a prescription for Truvada
as PrEP, the provider should conduct screenings for HIV and other sexually transmitted
infections, tests for hepatitis B, and an analysis of kidney functioning.106 During treatment,
the patient should receive quarterly HIV tests, periodic tests for kidney functioning as
needed, and counseling on safer-sex practices.107 Accordingly, PrEP is a prophylactic
therapy that requires continued engagement with healthcare providers.
Delivering this comprehensive prevention strategy to at-risk adults has proved challenging despite a deluge of media attention.108 Uptake has been slow, though adult pre103 CDC Guidelines, supra note 99. See also Burda, supra note 3, at 189–90 (discussing the CDC’s final
guidance and its implications for wider implementation of PrEP).
104 See Letter from Janet Woodcock, supra note 94 (detailing the FDA’s assessment of the long term medical
and behavioral risks). Subsequent to FDA approval, at least one double-blind, placebo-controlled study has
confirmed that the risk of kidney impairment is minimal. See also Kenneth K. Mugwanya et al., Changes in
Glomerular Kidney Function Among HIV-1-Uninfected Men and Women Receiving Emtricitabine-Tenofovir
Disoproxil Fumerate Preexposure Prophylaxis: A Randomized Clinical Trial, 175 JAMA Internal Med. 246,
252–53 (2015). Another recent study showed a mild loss in bone density in adults. Kathleen Mulligan et al., Effects
of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind,
Placebo-Controlled Trial: DXA Results from iPrEx, 61 Clinical Infectious Diseases 572 (2015), http://www.
ncbi.nlm.nih.gov/pubmed/25908682 [http://perma.cc/KL4N-3YDL] (last visited July 10, 2015). See Michael
Carter, Truvada PrEP Causes Only Mild Loss of Bone Mineral Density, AIDSMap, May 14, 2015, http://www.
aidsmap.com/iTruvadai-PrEP-causes-only-mild-loss-of-bone-mineral-density/page/2967903 [http://perma.cc/
3RSY-22CC]. Loss in bone density could be of greater concern in the context of PrEP for youth, though
research here is lacking.
105 See U.S. Food & Drug Admin., REMS for Truvada for a Pre-Exposure Prophylaxis (PrEP) Indication
3 (2014), http://1.usa.gov/1ChkFG7 [http://perma.cc/CKJ6-DK9G] [hereinafter Gilead REMS].
106 See Project Inform, Is Taking PrEP the Right Choice for You? 9 (2014), http://www.projectinform.org/
pdf/prep_msm.pdf [http://perma.cc/WX7F-YEYJ].
107 See Gilead REMS, supra note 105, at 3, 6. See also San Francisco AIDS Found., PrEP Facts 7–8
(2014), http://prepfacts.org/assets/PrEP_Facts_16-pager_brochure_mech_FINAL.pdf [http://perma.cc/H85TS6ZV] (containing plain-English information about the recommended PrEP regimen).
108

See Burda, supra note 3, at 174–75, 190–92. See also Shari Rudavsky, Drug Protects Against HIV But
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scriptions have begun to increase more rapidly as a result of coordinated efforts at the
state and local levels109 and through the support of national non-profit organizations.110 If
implementation of PrEP among adults has proved challenging, operationalizing PrEP for
youth will likely be even more difficult.
One reason for this is that the FDA has yet to approve Truvada as PrEP for use by atrisk youth, and no federal or state public health agency has issued guidance with respect to
PrEP for minors. According to the U.S. Public Health Service, “the data on the efficacy and
safety of PrEP for adolescents are insufficient.”111 There is some evidence that Truvada as
PrEP is safe and medically effective for young adults ages eighteen through twenty-four,112
but there are no completed studies pertaining to youth under eighteen years of age.113
Not Many Take It, Indianapolis Star, July 6, 2015, http://www.indystar.com/story/news/2015/07/06/drugprotects-hiv-many-take/29670455 [http://perma.cc/73JC-RFLV]; Abby Sewell, L.A. County Planning to
Distribute Controversial HIV Prevention Drug, L.A. Times, June 9, 2015, http://www.latimes.com/local/lanow/
la-me-ln-county-hiv-truvada-20150609-story.html [http://perma.cc/S87N-QEG7]; Jennifer Wright, Awareness
of Pill to Prevent HIV Is Growing, Phila. Daily News, June 26, 2015, http://articles.philly.com/2015-06-26/
news/63865437_1_truvada-medication-gilead-sciences-inc [http://perma.cc/6K5N-A342].
109 See, e.g., PrEP Prescriptions on Dramatic Upswing in New York State, AIDS Meds, May 14, 2015,
http://www.aidsmeds.com/articles/New_York_PrEP_1667_27238.shtml [http://perma.cc/8VGU-LQBX]
(noting recent estimation of 4,000 PrEP prescriptions in San Francisco and a rise in prescriptions in New York).
110 E.g., Statement, AIDS United, AIDS United Statement on Pre-Exposure Prophylaxis (PrEP) (Nov. 24,
2014), http://www.aidsunited.org/data/files/Site_18/AIDS%20United%20Statement%20on%20PrEP%20-%20
FINAL.pdf [http://perma.cc/JJ2F-4ASY] (noting that “AIDS United signed on to the June 17, 2014 community
statement by more than 160 organizations in support of the CDC guidelines [for Truvda as PrEP] and maintains
its support of this statement”).
111 See CDC Guidelines, supra note 99 (recommending PrEP “to reduce the risk of acquiring HIV infection
in adults”). Research is still lacking for adolescents under age eighteen, in part because of the medical,
ethical, and legal concerns with testing adolescent subjects. See R.J. Levine, Research Involving Adolescents
as Subject: Ethical Considerations, 1135 Ann. N.Y. Acad. Sci. 280 (2008), http://www.ncbi.nlm.nih.gov/
pubmed/18574234 [http://perma.cc/7LJC-XZYG]; Society for Adolescent Medicine, Guidelines for Adolescent
Health Research, 33 J. Adolescent Health 396 (2003), https://www.adolescenthealth.org/SAHM_Main/
media/Advocacy/Positions/Nov-03-Guidelines_for_Adolescent_Health_Research.pdf [http://perma.cc/M34U
-JSR5].
112 See, e.g., Sybil Hosek et al., Project PrEPare (ATN082): The Acceptability and Feasibility of an HIV
Pre-Exposure Prophylaxis (PrEP) Trial with Young Men who Have Sex with Men (YMSM), 62 J. Acquired
Immune Deficiency Syndromes 447 (2013), http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656981
[http://perma.cc/GFZ7-35P2].
113 A number of clinical concerns will likely need to be addressed prior to FDA approval. First, there is
concern about ensuring pre- and post-prescription testing, and adherence to the PrEP regimen, as well as
confirming minimal behavioral disinhibition and long-term side effects. See CDC Guidelines, supra note 99,
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Indeed, for the FDA to approve of Truvada as PrEP, studies will need to include adolescent
subjects.114
Nonetheless, the U.S. Public Health Service has provided clinical consider-ations to
physicians about PrEP for youth.115 Furthermore, it is common practice to treat minors with
at 42. One point that has not been explored is the added importance of the testing regimen for youth. Many
youth who acquire HIV through sexual risk-taking were unaware of their HIV status. Ctrs. for Disease Control
& Prevention, Vital Signs: HIV Infection, Testing, and Risk Behaviors Among Youths—United States, 61
Morbidity & Mortality Weekly Rep. 971 (2012), http://1.usa.gov/1SEp5cm [http://perma.cc/M33B-VT8M]
(finding, in 2009, that “[m]ore than half (59.5%)” of youths ages thirteen through twenty-four living with HIV
“were unaware of their infection, the highest for any age group”). As such, it is possible that at-risk youth
may seek PrEP prevention even though they are already infected. Because use of Truvada as PrEP by those
unknowingly infected face a risk (albeit relatively low) of ARV resistance, this issue is worthy of exploration
in the context of youth. See Emily Newman, PrEP and Drug Resistance: Cause for Concern?, Beta Blog
(Apr. 6, 2015), http://betablog.org/prep-and-drug-resistance-cause-for-concern [http://perma.cc/8ZKM-32PX].
Adherence is also a significant concern. Studies have found that “HIV-infected adolescents are especially
vulnerable to specific adherence problems on the basis of their psychosocial and cognitive developmental
trajectory,” and for HIV-negative youth who are not dependent upon ARVs to avoid onset of AIDS, issues of
adherence may be more pronounced. Nat’l Inst. of Health, Guidelines for the Use of Antiretroviral Agents
in HIV-1-Infected Adults and Adolescents I-9 (2015) (emphasis added), https://aidsinfo.nih.gov/contentfiles/
lvguidelines/adultandadolescentgl.pdf [http://perma.cc/6STZ-DEGS] (last visited July 5, 2015). More studies
are needed to confirm that potential long-term side effects associated with Truvada as PrEP (such as mild loss
in bone density and renal impairment) do not have a more pronounced effect on youth whose bodies are not yet
mature. But see Vania Giacomet et al., A 12-month Treatment With Tenofovir Does Not Impair Bone Mineral
Accrual in HIV-Infected Children, 40 J. Acquired Immune Deficiency Syndromes 448 (2005) (concluding that
“a TDF-containing antiretroviral regimen does not seem to impair bone mineral accrual in children showing
a good immunologic response to antiretroviral treatment”). Finally, there is growing concern that prescription
of PrEP to at-risk youth could lead to an increase in condomless intercourse and solidify the propriety of risktaking behavior during a period of increased neural plasticity and development of sexual identity.
114 Moore et al., supra note 6, at 40–42 (noting that parental consent is necessary for a minor subject to
participate in PrEP studies).
115 See CDC Guidelines, supra note 99, at 9, 42–43. The U.S. Public Health Service states the following
about the appropriateness of PrEP for adolescent minors:
Although the FDA labeling information specifies PrEP indications for “adults,” an age
above which an adolescent is considered an adult is not provided. None of the completed
PrEP trials have included persons under the age of 18. Therefore, clinicians should consider
carefully the lack of data on safety and effectiveness of PrEP taken by persons under 18
years of age, the possibility of bone or other toxicities among youth who are still growing,
and the safety evidence available when TDF/FTC is used in treatment regimens for HIVinfected youth. These factors should be weighed against the potential benefit of providing
PrEP for an individual adolescent at substantial risk of HIV acquisition.
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ARVs once diagnosed with HIV. Based upon some data confirming the safety and efficacy
of ARVs for youth under eighteen living with HIV, the CDC and the HHS has included
adolescents among its adult recommendations for early identification of HIV and early
treatment with ARVs.116 As such, a federal endorsement of ARVs as a prophylactic therapy
for HIV-negative youth less than eighteen years of age is realistic.
Federal endorsement of PrEP for youth is a threshold issue to operationalizing
PrEP for youth. An additional threshold issue is cost. In the United States, youth are
disproportionately impacted by poverty,117 and the percentage of youth living in poverty
and low income has increased over time.118 LGBTQ youth, including YMSM particularly
at risk of HIV infection, are “disproportionately represented among homeless youth” in the
United States.119 As such, concerns about the cost of healthcare to the patient are amplified
in the youth population. To be sure, PrEP is an expensive prophylactic therapy. One 2013
study using Medicare allowables estimated that the aggregate of costs in connection
with the PrEP regimen, including the wholesale price of Truvada (an average of $1,425
per month), laboratory work, and counseling, is approximately $18,000 per patient per
year in the United States.120 Although insurers are currently covering Truvada as PrEP,
Id. at 43.
116 Ctrs. For Disease Control & Prevention, Revised Recommendations for HIV Testing of Adults,
Adolescents, and Pregnant Women in Health-Care Settings, 55 Morbidity & Mortality Weekly Rep. 1, Sept.
22, 2006, http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm [http://perma.cc/8GR4-VB5E]; U.S.
Dep’t of Health & Hum. Servs., Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and
Adolescents, https://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultAndAdolescentGL.pdf [http://perma.cc/
E6PW-4BAH] (last updated Apr. 8, 2015).
117 While children comprise twenty-four percent of the United States population, they represent thirty-four
percent of all people living in poverty. Sophia Addy et al., Nat’l Ctr for Children in Poverty, Basic Facts
About Low-Income Children: Children Under 18 Years, 2011 1 (2013) http://www.nccp.org/publications/
pdf/text_1074.pdf [http://perma.cc/9XGW-KT6R].
118

See id. at 2.

119 Andrew Cray et al., Ctr. for Am. Progress, Seeking Shelter: The Experiences and Unmet Needs of
LGBT Homeless Youth 7 (2013), https://www.americanprogress.org/issues/lgbt/report/2013/09/26/75746/
seeking-shelter-the-experiences-and-unmet-needs-of-lgbt-homeless-youth [https://perma.cc/ZU24-9KSA].
120 Burda, supra note 3, at 200 (citing Michael Horberg & Brian Raymond, Financial Policy Issues for
HIV Pre-Exposure Prophylaxis: Cost and Access to Insurance, 44 Am. J. Preventive Med. S125, S125 (2013),
http://www.ajpmonline.org/article/S0749-3797(12)00696-4/pdf [http://perma.cc/4D2U-TST4]). It appears that,
since 2013, the average wholesale price of Truvada has increased. See Panel on Antiretroviral Guidelines
for Adolescents & Adults, U.S. Dep’t of Health & Human Servs., Guidelines for the Use of Antiretroviral
Agents in HIV-1-Infected Adults and Adolescents K-20, http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultand
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PrEP may be unaffordable to many adults due to maximum out-of-pocket deductibles,
coinsurance, and co-pays.121 In the context of youth access to PrEP, these costs would
likely be prohibitive, especially because most insured youth are dependent on a parent or
caregiver’s ability—and willingness—to pay. Making PrEP accessible to at-risk youth will
require the development of solutions that render PrEP entirely cost-free.122
The threshold issues of clinical safety/efficacy of PrEP for youth and the cost of PrEP
will require careful analysis by experts in these fields. Yet there is a primacy to addressing
these concerns; there is little chance of operationalizing PrEP for youth on a wide scale
without FDA approval and securing cost-free delivery. Nonetheless, while the FDA has not
approved Truvada as PrEP for use by individuals under eighteen years of age, physicians
have the ability to prescribe Truvada as PrEP to this group.123 In fact, some providers may
have already begun doing so. In light of the off-label availability of Truvada as PrEP to
adolescentgl.pdf [https://perma.cc/3BGN-ZX3F] (last updated Apr. 8, 2015) (listing average wholesale price of
Truvada as $1,539.90).
121

Burda, supra note 3, at 201.

122 Private and public co-pay assistance programs that cover a portion of the cost depending upon income,
such as the Gilead Co-Pay Assistance Program for Truvada and Washington State’s Pre-Exposure Prophylaxis
Drug Assistance Program, have made PrEP more affordable to many adults. Eligibility for Washington’s
program is not age-dependent, while those eligible for Gilead’s program must be age eighteen or older. See
Wash. Dep’t of Health, Pre-Exposure Prophylaxis Drug Assistance Program (PrEP DAP) Confidential
Application, at 3, http://www.doh.wa.gov/Portals/1/Documents/Pubs/150-053-PrEPDAPApplication.pdf
[http://perma.cc/MEQ3-7QPW] (last visited July 6, 2015) (listing eligibility requirements); Truvada for PrEP
Medication Assistance Program, Gilead, http://www.gilead.com/responsibility/us-patient-access/truvada%20
for%20prep%20medication%20assistance%20program [http://perma.cc/6ZWJ-9TKT] (last visited July 10,
2015) (stating that the program “assists eligible HIV-negative adults”). In the future, co-pay programs should
not condition eligibility upon age. Those eligible for assistance should include youth insured as dependents,
youth insured as dependents but who decline to provide details of insurance coverage due to privacy concerns,
and uninsured youth.
Public health advocates and policymakers have also begun pushing for municipal PrEP subsidy programs.
In San Francisco, for example, City Supervisor David Campos recently proposed a measure to allocate funds
to subsidize the out-of-pocket costs associated with PrEP for those who cannot afford the prophylaxis. See
Lydia O’Connor, San Francisco May Be the First City to Give Out Free HIV-Prevention Pills, Huffington
Post, Sept. 19, 2015, http://www.huffingtonpost.com/2014/09/19/san-francisco-free-hiv-prevention-pillsprep-truvada_n_5847454.html [http://perma.cc/2HXJ-XM6J].
123 Tanya L. Kowalczyk Mullins et al., Abstract, Clinician Attitudes Toward CDC Interim Pre-exposure
Prophylaxis (PrEP) Guidance and Operationalizing PrEP for Adolescents, 29 AIDS Patient Care STDs 193
(2015), http://www.ncbi.nlm.nih.gov/pubmed/25692683 [http://perma.cc/4NE8-PC5X] (“[O]ral PrEP may be
used off-label for youth.”).
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youth, it is important to begin addressing the major accessibility and acceptability hurdles
that may prohibit uptake.
In Part II, I argue that the major accessibility hurdle to PrEP for youth is parental
involvement in youth healthcare decisions. Pursuant to the laws of every U.S. jurisdiction,
breaches of confidentiality resulting from parental consent and notification are not just
permissible under state law, they’re compelled. Such breaches, or the threat of such
breaches, form a major barrier to youth access to sexual healthcare therapies such as PrEP.
In Part III, I argue that that major acceptability hurdle to PrEP for youth will likely be
stigma resulting from incomplete HIV prevention education.
II. Ensuring PrEP Accessibility Without Parental Involvement
Most youth lack independence from parental figures.124 In the healthcare context, the
general rule is that minors—youth under the age of majority pursuant to state law, most often
under eighteen years of age—are incapable of making informed decisions about health and
welfare that require understanding and weighing risks and benefits. State laws shift that
responsibility to the parental figure.125 For example, with limited exceptions, surgeons may
not perform non-emergency surgery on minors without obtaining parental consent.126 This
is true even if the minor has the mental faculties to decide for him or herself whether the
benefits outweigh the risks. Thus, the general rule is that minors lack confidential healthcare
as a result of the involvement of third-party decision-makers. Ensuring that minors have
access to confidential sexual healthcare is a vexing problem, and there is much scholarship
devoted to the issue.127 One author put the dilemma this way: “[W]hat health care services
124 See Kimberly M. Mutcherson, Whose Body Is It Anyway? An Updated Model of Healthcare DecisionMaking Rights for Adolescents, Cornell J.L. & Pub. Pol’y 251, 257 (2005) (noting that “[w]hile adolescent
minors have more legal authority than they used to have, for the most part they still must follow the direction
of their parents”).
125 See Richard C. Boldt, Symposium: Adolescent Decision Making: Legal Issues With Respect to Treatment
for Substance Misuse and Mental Illness, 15 J. Health Care L. & Pol’y 101, 105 (2012); Alicia Ouellette,
Body Modification and Adolescent Decision Making, 15 J. Health Care L. & Pol’y 101, 105 (noting that “the
law vests parents with decision-making authority of teenagers”); Jennifer L. Rosato, Let’s Get Real: Quilting a
Principled Approach to Adolescent Empowerment in Health Care Decision-Making, 51 DePaul L. Rev. 769,
769 (2002) (“In the health care context, . . . even older adolescents are presumed incompetent to make basic
health care decisions.”).
126 See generally Ouellette, supra note 123, at 106–07 (discussing parental consent in the context of cosmetic
surgery).
127

E.g., Diane M. Reddy et al., Effect of Mandatory Parental Notification on Adolescent Girls’ Use of Sexual
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[would] competent adults . . . forego if their employers, spouses, or family members were
notified of their medical procedures and consultations[?]”128
Indeed, there is often a conflict between the interests of minors and their parents in the
context of HIV-related health decisions that works as a disincentive to prompt treatment
of the minor. This can have devastating consequences on the health of the minor. The
California Supreme Court stated it aptly:
[P]articularly in matters concerning sexual conduct, minors frequently
are reluctant, either because of embarrassment or fear, to inform their
parents of medical conditions relating to such conduct, and consequently
. . . there is a considerable risk that minors will postpone or avoid seeking
needed medical care if they are required to obtain parental consent before
receiving medical care for such conditions.129
This observation is well established in social science literature. In seeking sexual
healthcare, approximately half of all adolescents would prefer to eschew services than
permit their providers to notify a parent of their decisions to take birth control.130 Another
eleven percent of adolescents would delay STI testing and treatment if the provider were
required to notify a parent.131
In an effort to protect the health of minors in situations where they would sooner forgo
treatment than secure the consent of a parent or guardian, lawmakers have passed laws
acting as exceptions to the general rule that minors may not make their own healthcare
decisions. These exceptions, such as those permitting minors to consent to STI treatment,
permit sensitive healthcare decisions without adult consent and, in some instances, further
secure the confidentiality of minors in such situations by permitting providers to forgo

Health Care Services, 288 JAMA 710 (2002), http://jama.jamanetwork.com/article.aspx?articleid=195185
[http://perma.cc/CA2M-92BW] (concluding that “[m]andatory parental notification for prescribed
contraceptives would impede girls’ use of sexual health care services, potentially increasing teen pregnancies
and the spread of STDs”); Arshagouni, supra note 12, at 323.
128 Arshagouni, supra note 12, at 323.
129 Am. Acad. of Pediatrics v. Lungren, 940 P.2d 797, 802 (Cal. 1997).
130

N. Labor et al., Healthy Teens Initiative, supra note 11.

131

Id.
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parental notification.132 In HIV prevention advocacy, there is increasing interest in how
these exceptions may facilitate confidential access to PrEP therapy for minors.133
In the next section, I divide my analysis into two broad categories of laws affecting
confidential access to healthcare for minors: (a) state consent laws; and (b) parental
notification laws. In both, I consider the implications for operationalizing PrEP for minors
and make specific suggestions for advocates, policymakers, and lawmakers.
A. State Consent Laws
Minor access to confidential healthcare, particularly sexual healthcare, is complicated
by a lack of uniformity among the states as to what medical services may be provided
without parental consent, and there is a great deal of provider confusion and concern about
liability. The liability concerns of providers are compound. For a provider to avoid liability
for battery, the patient must effectively consent to treatment.134 To avoid professional negligence, such consent must be informed and properly disclosed.135 Additionally, a provider
who furnishes care to marginalized youth may now need to be concerned about a potential
criminal charge of contributing to the delinquency or neglect of a minor for facilitating
conduct considered morally reprehensible.136 These liability fears are motivating providers
to investigate the variability in adolescent health and wellness-related laws across United
States jurisdictions.137 In the context of PrEP, a therapy not without political controversy,
provider concerns about whether minors may consent are amplified, and may result in the
delay of necessary HIV prevention or blanket bans on PrEP for youth altogether.
132

See id.

133 See generally Culp & Caucci, supra note 6, at 119 (suggesting that “efforts to provide clinical care to
minors, including young MSM, may be complicated by a lack of clarity regarding parental consent requirements
with respect to medical services”).
134

Mykitiuk et al., supra note 19, at 994.

135

Id.

136 In a much-watched Virginia case, an adult transgender activist was charged with contributing to the
delinquency of a minor, a class-1 misdemeanor, for assisting a seventeen-year-old suicidal trans teenager
in finding counseling and housing because the teenager’s father disapproved. See Brad Kutner, Lynchburg
Transadvocate Arrested After Assisting At-Risk Youth, GayRVA.com (Apr. 9, 2015), http://www.gayrva.com/
news-views/lynchburg-transadvocate-arrested-after-assisting-at-risk-youth [http://perma.cc/62WZ-84KZ].
137 E-mail from Jason Potter Burda to Daniel Bruner (May 19, 2015, 10:06 EST) (on file with author);
e-mail from Daniel Bruner to Jason Potter Burda (May 19, 2015, 11:37 EST) (on file with author); e-mail from
Daniel Bruner to Jason Potter Burda (May 19, 2015, 18:24 EST) (on file with author).
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The purpose of this section is to provide a framework for understanding the patchwork
of state consent laws pertaining to minor consent to medical treatment, with the specific
goal of pinpointing statutory inroads to operationalizing PrEP for youth without parental
consent. I divide these state consent laws into three kinds: (1) laws permitting minors
to self-consent in specific healthcare-related situations, focusing here on STI prevention
and treatment; (2) laws permitting certain minors to consent to general medical care
based on particular personal, social, or family circumstances; and (3) state emergency
medical treatment laws that, rather than grant decision-making authority to minors, merely
imply parental consent. Of these three types of laws, I argue that laws permitting minors
to consent in connection with STI prevention and treatment, which exist in all United
States jurisdictions in various forms, offer the most realistic state-level opportunity for
operationalizing PrEP on a confidential basis. As such, I conducted a comprehensive
survey of these STI consent laws in all fifty United States jurisdictions and the District of
Columbia, the results of which I summarize next.
1. Minor Consent Pursuant to STI Consent Statutes
All United States jurisdictions and the District of Columbia permit providers to rely
on a minor’s consent in the context of sexually transmitted diseases.138 These statutes are a
legislative recognition that, “while parental involvement in minors’ health care decisions is
desirable, many minors will not avail themselves of important services if they are forced to
138 Culp & Caucci, supra note 6, at 121; Moore et al., supra note 6, at 41. Only South Carolina lacks
a dedicated statute permitting minors to consent to STI services. However, South Carolina’s broad consent
statute permits minors to receive any care a physician deems necessary without parental consent. Id. at 121. By
implication, minors may self-consent to STI services in South Carolina.
States also permit minors to consent to care in the pregnancy and family planning context, as well as in
the addiction treatment context. Some family planning exceptions may enable HIV-negative female minors
considering pregnancy with an HIV-positive male partner to consent to PrEP. See, e.g., Del. Code Ann. tit. 13,
§ 710(a) (2015) (“A minor 12 years of age or over who professes to be either pregnant . . . or who professes
to be exposed to the chance of becoming pregnant, may give written consent . . . to any licensed physician,
hospital or public clinic for any diagnostic, preventive, lawful therapeutic procedures, medical or surgical care
and treatment . . . . ”) (emphasis added); Va. Code Ann. § 54.1-2969(E)2 (2015) (permitting minor consent for
“[m]edical or health services required in case of birth control, pregnancy or family planning”). Some addiction
exceptions may allow IDU-using minors, to consent to PrEP. See, e.g., N.H. Rev. Stat. Ann. § 318-B:12-a
(2015) (permitting “[a]ny minor 12 years of age or older [to] voluntarily submit himself to treatment for drug
dependency . . . or any problem related to the use of drugs . . . without the consent of a parent, guardian, or
any other [adult caregiver]”) (emphasis added); Tenn. Code Ann. § 63-6-220(a) (2015) (“Physicians may treat
juvenile drug abusers without prior parental consent.”). However, further discussion of these ideas is beyond
the scope of this Article.
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involve their parents.”139 As such, they are an excellent starting point for operationalizing
PrEP.140
Comprehensive research conducted for this Article141 among the fifty United States and
the District of Columbia indicates that statutes permitting minors to consent to services
in connection with sexually transmitted diseases142 may be divided into three types: (1)
those that are narrowly tailored, permitting minor self-consent to care attendant to actual
or suspected STIs; (2) those that are more broadly tailored, permitting minor self-consent
to STI services in the event the of actual or perceived exposure to an STI; and (3) those
that are tailored the broadest, permitting minors to consent to preventive STI care. This
framework provides a useful means of synthesizing the numerous variations among these
statutes and developing advocacy recommendations with respect to each type.
a. Narrowly-Tailored Statutes: Diagnosis and Treatment of STIs
Nearly half of all United States jurisdictions have narrowly tailored STI consent
statutes.143 These statutes typically limit minor consent to testing, treatment, and prescription

139 See Guttmacher Inst., State Policies in Brief, An Overview of Minors’ Consent Law (2015),
http://www.guttmacher.org/statecenter/spibs/spib_OMCL.pdf [http://perma.cc/Y6T8-ZA6F]. See also CDC
Guidelines, supra note 99, at 42 (“Parental/guardian involvement in an adolescent’s health care is often
desirable but is sometimes contraindicated for the safety of the adolescent.”).
140 Two peer-reviewed studies have addressed the issue of minor access to PrEP pursuant to STI consent
statutes. See Culp & Caucci, supra note 6, at 119; Moore et al., supra note 6, at 40. Culp and Caucci surveyed
minor STI consent statutes and implications for operationalizing PrEP for self-consenting minors pursuant
to such statutes. Culp & Caucci, supra note 6, at 120. This study was limited to minor STI consent statutes
and did not consider other statutory exceptions to the general rule that minors may not consent to their own
healthcare. See id. at 119. In the second study, Moore and associates argued that the patchwork of minor STI
consent statutes across U.S. jurisdictions is a barrier to conducting research regarding PrEP and other STI
pharmacologies on adolescent subjects. See Moore et al., supra note 6, at 40.
141 The research conducted in connection with STI exceptions was executed independently of, and the results
confirmed by, Culp and Caucci’s study. Moore and associates’ 2016 article incorporated Culp and Caucci’s
findings. See Moore et al., supra note 6, at 44.
142 The definition of STI varies among the states. Some statutes refer to STIs as “sexually transmitted
disease,” “venereal disease,” or “reportable disease.” Some minor STI consent statutes specifically mention
HIV. See, e.g., Mich. Comp. Laws § 333.5127(1) (2015) (includes specific mention of HIV); Or. Rev. Stat. §
109.610 (2016) (includes specific mention of HIV); 23 R.I. Gen. Laws § 23-6.3-3(l) (2016) (includes specific
mention of HIV).
143

See infra Appendix, Tbl.1.
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in connection with actual STI infections.144 Some statutes specify a minimum age, and
some are silent as to age.145 With regard to the type of care permitted, many states explicitly
permit the minor to consent to the diagnosis and treatment of STIs,146 yet do not explicitly
permit minors to consent to preventive care.147 Because PrEP is not diagnostic in nature,
in these jurisdictions (which comprise almost half of all U.S. states), minors would likely
be required to obtain parental consent for PrEP therapy unless it may be characterized as a
“treatment” under these statutes.148 However, the statutes themselves rarely provide insight
as to whether treatment includes care that is preventive in nature. To be sure, with few
exceptions,149 STI consent statutes typically do not define the term “treatment” at all.

144 See id. Some statutes that purport to limit the care to diagnosis and treatment of STIs are, in fact, more
vague and deserve further investigation. For example, Kentucky’s minor STI consent statute states that “[a]ny
physician . . . with the consent of [the] minor may advise, prescribe for, and treat such minor regarding venereal
disease.” Ky. Rev. Stat. Ann. § 214.185 (West 2015) (emphasis added). It is unclear whether “prescribe for . . .
venereal disease” requires the minor to have a confirmed diagnosis for that disease. In this statute, because the
legislature specifically broke out treatment as a separate consent item, there is an argument that a minor does
not need to be actually diagnosed with an STI to receive a prescription in connection with preventing that STI.
Additionally, in the Kentucky statute, it is unclear what “treat such minor regarding” an STI means. PrEP is
a treatment regarding HIV. This may open the door to PrEP without parental consent. Missouri’s minor STI
consent statute is equally as vague, permitting minors to consent “in case of . . . [v]enereal disease.” Mo. Rev.
Stat. § 431.061(4) (2015) (emphasis added). PrEP is prescribed in case of HIV infection. This, too, may open
the door to PrEP without parental consent.
145 Compare N.H. Rev. Stat. Ann. § 141-C:18 (2015) (minimum age of fourteen) with Ky. Rev. Stat. Ann.
§ 214.185 (no minimum age specified).
146

See, e.g., N.H. Rev. Stat. § 141-C:18; infra Appendix, Tbl.1.

147 Moore and associates proffer that there exists “little evidence” that consent statutes permitting minor
self-consent to STI treatment were “consciously crafted” by legislatures to omit preventive care. Moore, supra
note 6, at 42.
148 Culp & Caucci, supra note 6, at 122 (“[A] provider’s ability to prescribe PrEP to adolescents under current
law may hinge on whether PrEP is determined to be more analogous to a preventive or a treatment measure.”).
149 E.g., Tex. Health & Safety Code Ann. § 313.002(6) (West 2015) (defining “treatment” in the context
of consent to medical care generally as “a health care treatment, service, or procedure designed to maintain
or treat a patient’s physical or mental condition, as well as preventative care”) (emphasis added). Moore and
associates maintain that there exists “little evidence” that consent statutes permitting minor self-consent to STI
treatment were “consciously crafted [by legislatures] to exclude prevention.” Moore et al., supra note 6, at 42.
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Nonetheless, some statutes pertaining to minor consent to general medical care,150 as
well as statutes pertaining to HIV confidentiality and testing,151 do define “treatment” to
include prevention, and there is little to suggest that the definition of treatment in connection
with minor STI consent should be any different. Other health- and safety-related laws
provide further support for this interpretation. For example, jurisdictions define “treatment”
as including preventive care in the context of nursing,152 sports medicine,153 disability,154
mental health,155 and healthcare regulation.156 Additionally, federal occupational safety
regulations applicable to all U.S. jurisdictions consider the prescription of all medications,
including prophylaxes, as treatments.157 Case law, too, may provide further support.158
These primary authorities (in areas of health, wellness, and safety) all support the idea
that prevention—and, by extension, PrEP—is a type of treatment and might be furnished
150 E.g., Del. Code Ann. tit. 13, § 707(a)(2) (2015) (defining “medical treatment” including “ordinary and
necessary medical and dental examination and treatment, including blood testing, preventive care including
ordinary immunizations, tuberculin testing and well-child care”); Fla. Stat. § 743.0645(1)(b) (2015) (defining
“medical care and treatment” as “includ[ing] ordinary and necessary medical . . . treatment, including blood
testing, preventive care including ordinary immunizations, tuberculin testing, and well-child care”); Or. Rev.
Stat. § 109.572(4) (2015) (defining “medical treatment” as including “ordinary and necessary medical, dental
and optical examination and treatment and preventive care including ordinary immunizations, tuberculin
testing and well-child care . . .”).
151 Ill. Admin. Code. tit. 77 § 693.10 (2015) (defining “treatment” as including “services for prevention,
diagnosis, and medical management of STIs”).
152 E.g., Fla. Stat. § 464.003(18) (2015) (defining “nursing treatment” as including care for “the prevention
of illness”).
153 E.g., D.C. Code § 3-1201.02(2A-ii)(D)(iii) (2015) (defining “treatment” as including “the prevention,
evaluation . . . management, treatment . . . or reconditioning of an athletic injury”).
154 E.g., Ark. Code Ann. § 20-48-1102(5A)(B) (2015) (defining “early intervention day treatment” as
including “preventive . . . therapies”).
155 N.M. Stat. Ann. § 24-7B-3(G) (2015) (defining “mental health treatment” as including services “provided
for the prevention of . . . mental illness”).
156 Minn. R. 9505.1696 (2015) (defining “treatment” as “the prevention, correction, or amelioration of a
disease . . .”).
157 See Letter from Keith Goddard, U.S. Dep’t of Labor, to Dave Beyer (Mar. 10, 2005), https://www.osha.
gov/pls/oshaweb/owadisp.show_document?p_table=INTERPRETATIONS&p_id=25233 [https://perma.cc/
M6X8-FTX5].
158 See generally Parents United for Better Sch., Inc. v. Sch. Dist. of Phila. Bd. of Educ., 978 F. Supp. 197,
207 (E.D. Pa. 1997), aff’d, 148 F.3d 260 (3d Cir. 1998) (finding condom distribution a health service rather than
treatment in part because condoms are “non-invasive” and “do not require medical training or supervision for
their use,” but placing weight on the prophylactic, non-diagnostic nature of condoms).
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without parental consent in treatment-specific jurisdictions. Finally, from the clinical
perspective, it is appropriate to regard PrEP as analogous to a treatment because PrEP is a
comprehensive regimen involving far more than HIV testing and diagnosis. Because PrEP
involves a prescription, periodic testing, counseling, and monitoring, as well as supervision
by a physician or advanced practice nurse in perpetuity, it more closely resembles actual
HIV treatment than traditional prevention services.
If the definition of “treatment” includes preventive care, providers in narrowly
tailored STI consent jurisdictions—almost half of the United States—may be able to rely
on an at-risk minor’s consent to PrEP therapy. Therefore, in jurisdictions with narrowly
tailored STI consent statutes, it will be important for advocates to work with legislatures
and policymakers to clarify that the term “treatment” includes preventive care. In the
alternative, advocates may work with legislatures to amend narrowly tailored statutes to
permit self-consent to diagnosis, treatment, and preventive care.159
b. Broader Statutes: Care Related to, or Prescription for, STIs
A number of jurisdictions have broader minor STI consent statutes, specifying that
minors may consent not only to the diagnosis and treatment of STIs, but also to “care”
related to an STI in the event of an actual or suspected exposure.160 In Indiana, for example,
a physician may rely on the consent of a minor who has, or suspects he or she has, an STI to
furnish “medical or hospital care or treatment.”161 In jurisdictions specifying that a provider
may furnish “care” to self-consenting minors, whether PrEP is included may depend upon
the definition of “care.” Some statutes specify this definition. In Indiana, for example,
“health care” means “any care, treatment, service, or procedure to maintain, diagnose, or
treat an individual’s physical or mental condition.”162 Because PrEP therapy is prescribed
to maintain an individual’s current HIV-negative status, it is likely that PrEP would meet
Indiana’s statutory definition of “care.” Advocates in jurisdictions permitting physicians
to rely on minor self-consent in the provision of “care” related to actual or suspected STI
exposure should consult statutory definitions of care and seek legislative clarification if
needed. Advocates may also need to seek clarification as to whether their jurisdiction’s

159

See infra Appendix, Tbl.3.

160

See infra Appendix, Tbl.2.

161

Ind. Code § 16-36-1-3(d) (2015) (emphasis added); see infra Appendix, Tbl.2.

162

Ind. Code § 16-36-1-1(2015).
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statute would permit minor consent even if a minor’s professed suspicions are ultimately
unsubstantiated.
Other jurisdictions permit physicians to “prescribe for” actual or suspected exposure
to an STI. In New York, for example, a physician may “prescribe for” a minor who has
actually been infected with an STI “or has been exposed to infection” without obtaining
parental consent.163 In these jurisdictions, there is little to suggest that a minor who believes
he or she has been exposed to HIV through risky behavior could not self-consent to a
pharmological prophylaxis. In fact, legislatures in a minority of jurisdictions have made
this explicit, permitting minor consent to prophylactic treatment in the event of suspected
exposure to HIV.164
While statutes permitting minors to consent to “care” for, or to receive prescriptions in
the event of, actual or suspected exposure to STIs are an improvement over narrow statutes
only permitting self-consent to the diagnosis and treatment of STIs, there are still a number
of uncertainties in these statutes that may lead to provider confusion and delay as related to
PrEP. Therefore, advocates should work in concert with legislatures to amend these statutes
and explicitly permit minor self consent to the prevention of STIs.
c. Broadest Statutes: Adding Preventive Care
Seven United States jurisdictions explicitly permit minors to consent to preventive
163 N.Y. Pub. Health Law § 2305(2) (McKinney 2015) (emphasis added). It is unclear whether the New
York statute requires actual exposure (say, in the occupational context of a documented pin prick with HIVinfected blood) or whether suspected or feared exposure to STI (say, in the more common scenario a YMSM
whose concern over recent condomless intercourse with a partner of unknown HIV status) would be sufficient.
164 See Kan. Stat. Ann. § 65-2892 (2015); Neb. Rev. Stat. § 71‐504 (2015); S.D. Codified Laws § 34-23-16
(2015); infra Appendix, Tbl.2. In South Dakota, for example, minors may consent to the “prescri[ption] for and
treat[ment] . . . for [STIs], including prophylactic treatment for exposure to [STIs] whenever such person is
suspected of having a venereal disease or contact with anyone having a venereal disease.” S.D. Codified Laws
§ 34-23-16 (emphasis added); see also Kan. Stat. Ann. § 65-2892 (2015) (“Any physician, upon consultation
by any person under eighteen (18) years of age as a patient, may, with the consent of such person who is hereby
granted the right of giving such consent, make a diagnostic examination for venereal disease and prescribe for
and treat such person for venereal disease including prophylactic treatment for exposure to venereal disease
whenever such person is suspected of having a venereal disease or contact with anyone having a venereal
disease.”); Neb. Rev. Stat. § 71-504 (2015) (“[M]ake or cause to be made a diagnostic examination for
sexually transmitted diseases and prescribe for and treat such person for sexually transmitted diseases including
prophylactic treatment for exposure to sexually transmitted diseases whenever such person is suspected of
having a sexually transmitted disease or contact with anyone having a sexually transmitted disease.”).
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STI care,165 which by implication would permit providers to rely on the consent of minors
to PrEP and other pharmacological HIV prevention therapies. In Oklahoma, for example,
minors are permitted to consent to preventive STI care in the event of prior infection
with an STI.166 California imposes an age restriction of age twelve or older,167 while other
jurisdictions permit self-consent to preventive STI care at any age.168 Pursuant to the
broadest minor STI consent law in the nation, the District of Columbia permits minors of
any age to consent to “any services which he or she requests for the prevention, diagnosis,
or treatment of . . . [a] sexually transmitted disease.”169 Delaware specifically permits a
minor twelve years old or over the ability to self-consent to preventive care if the minor
believes she is infected.170
Thus, in those seven jurisdictions permitting minors to self-consent to preventive
STI care, the language of these statutes implies that minors may self consent to PrEP,
which is prescribed to prevent HIV. However, most statutes do not typically define the
terms “prevention” or “preventive care.” These terms are commonly understood as
including preventions such HIV screening and counseling, but it is certainly not clear
whether these terms may be fairly interpreted, consistent with legislative intent, to include
165

See infra Appendix, Tbl.3. See also Moore et al., supra note 6, at 41.

166 Okla. Stat. tit. 63, §§ 2601, 2602 (2015). In Oklahoma, if a minor is or has been infected with a reportable
communicable disease, the minor may consent to prevention, diagnosis, and treatment of reportable diseases.
The statute does not specify that prevention must relate to the same STI with which the minor was previously
infected. Id. Under the Oklahoma statute, it may be possible for a minor previously infected with syphilis, for
example, to self-consent to prescription of PrEP to prevent HIV infection.
167 Cal. Fam. Code § 6926(a) (West 2015) (“A minor who is 12 years of age or older may consent to medical
care related to the prevention of a sexually transmitted disease.”).
168 D.C. Mun. Regs. tit. 22, § 600.7, 7(c) (2015) (“A minor of any age may consent to health services which
he or she requests for the prevention, diagnosis, or treatment of . . . [a] sexually transmitted disease.”); Iowa
Code § 139A.35 (2015) (“A minor shall have the legal capacity to act and give consent to provision of medical
care or services to the minor for the prevention, diagnosis, or treatment of a sexually transmitted disease or
infection by a hospital, clinic, or health care provider.”); N.C. Gen. Stat. § 90-21.5(a) (2015) (“Any minor may
give effective consent . . . for medical health services for the prevention, diagnosis and treatment of . . . venereal
disease” and other reportable diseases).
169

D.C. Mun. Regs. tit. 22, § 600.7.

170 Del. Code Ann., tit. 13, § 710(a) (2015) (“A minor 12 years of age or over who professes to be . . . afflicted
with contagious, infectious or communicable diseases . . . may give written consent . . . for any diagnostic,
preventive, lawful therapeutic procedures, medical or surgical care and treatment.”). See also Mont. Code Ann.
§ 41-1-402(2)(c) (2015) (“[A] minor who professes or is found to be . . . afflicted with any [STI]” may consent
to the “prevention, diagnosis, and treatment of those conditions specified in this subsection.”).
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pharmacological prophylaxes, which carry potential long-term side effects and require
close medical supervision. Clarification will be needed.
Notwithstanding this concern, advocates should begin to focus on jurisdictions that
explicitly include preventive care as the starting point in operationalizing PrEP for selfconsenting minors pursuant to STI consent statutes. Providers in these states should
investigate developing policies, in collaboration with legal counsel, that permit minors
to consent to PrEP, closely tailoring those policies to the specific requirements in their
respective minor STI consent statute. One jurisdiction that is well-positioned to make
advances on PrEP for at-risk youth without third party consent is the District of Columbia,
which as of 2013, had almost three times the number of new HIV infections among
adolescents age thirteen through nineteen years per 100,000 population (43.1%, n=832)
than Louisiana, the state with the next highest rate of infection (15.4%, n=297).171
However, state-level solutions such as this are only one piece of the puzzle. Federal
solutions are also needed to address, among other issues, the choice of law complications
that may lead to provider confusion and the delay of necessary care. While choice of law is
more assured with patients who receive care at the provider’s home base, choice of law is
more nebulous when providers interact with extra-jurisdictional patients outside the brickand-mortar clinical environment. Providers and administrators often communicate with
extra-jurisdictional patients via phone, through electronic patient portals, or using other
virtual means. Must a clinic that operates in the District of Columbia but also draws its
patient base from a number of other jurisdictions (such as Maryland, Virginia, Delaware,
West Virginia, and Pennsylvania)172 consider the STI consent laws of other jurisdictions
when its physicians or staff interact with the patient within his or her home jurisdiction in
connection with care furnished pursuant to an STI consent law? If so, which STI consent
law applies? While such D.C.-based clinic could furnish PrEP to at-risk youth without
parental consent pursuant to the District of Columbia’s broad minor STI consent statute
(which includes STI prevention),173 the ability of this provider to do the same is more
tenuous when interacting telephonically or electronically with patients living in Maryland
171

See CDC Surveillance Slideshow, supra note 44, at 9.

172 E-mail from Daniel Bruner to Jason Potter Burda (Oct. 2, 2015, 16:18 EST) (on file with author). See
also Whitman-Walker Health Annual Report 3 (2013), http://ymlvr1c1g6r30e7oiyxve462.wpengine.netdnacdn.com/wp-content/uploads/2014/11/WWH-2013-Annual-Report_FINAL.pdf
[http://perma.cc/MVK42S78] (noting that nearly 70% of patients came from the District of Columbia, 16% of patients from Maryland,
and 11% from Virginia in 2013).
173

See CDC Surveillance Slideshow, supra note 44.
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and Virginia, where the minor STI consent statutes are narrower and pertain only to
diagnosis and treatment of STIs.174 If communications occur, can the provider continue
to rely on the minor’s original consent made in the District of Columbia? This choice
of law complication is paradigmatic of the challenges that arise as a result of significant
variations in STI consent laws across United States jurisdictions. Such challenges have the
potential to engender provider confusion and delay in providing services to at-risk minors,
which in turn may lead to altogether preventable HIV infections. This is one justification
for developing federal solutions that would help streamline confidential access to PrEP
for minors.
2. Minor Consent Pursuant to Emancipation Exceptions
A minor who has reached the age of majority is automatically considered emancipated,
but those under the age of majority who achieve legal emancipation, either by statutory
mandate or judicial decree, have a greatly expanded range of rights and responsibilities.175
All states have laws pertaining to the emancipation of minors who have not yet reached
the age of majority. Emancipation may be de jure or de facto. De jure emancipation, or
emancipation by law, occurs through court intervention, where a minor petitions a court
to grant him or her the rights and responsibilities of adulthood. De jure emancipation,
while an important tool, is of minimal significance for operationalizing PrEP for at-risk
minors. Concerns about cost, privacy, and delay inherent in court intervention would likely
be prohibitive for the majority of at-risk youth. Thus, operationalizing PrEP for minors
without parental consent will require reviewing more economically feasible, confidential,
and efficient solutions.
De facto emancipation, or emancipation by right, is enabled by state statute and
occurs when a minor has achieved a certain status or has certain “individual or social
circumstances.”176 In these limited circumstances, the law presumes that the minor has the
capacity to understand the risks and benefits of adult activities, and the minor may consent

174 Md. Code Ann., Health-Gen. § 20-102(c)(3) (West 2015) (“A minor has the same capacity as an adult
to consent to . . . treatment for or advice about venereal disease.”); Va. Code Ann. § 54.1-2969(E)1 (2015)
(consent of minor is valid for “[m]edical or health services needed to determine the presence of or to treat
venereal disease”).
175

See Arshagouni, supra note 12, at 334.

176 Rhonda Gay Hartman, Coming of Age: Devising Legislation for Adolescent Medical Decision-Making,
28 Am. J.L. & Med. 409, 421 (2002).
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to general medical care177 without court intervention. Thus, a minor who becomes a member
of the armed forces,178 enters into a marriage or receives a divorce,179 graduates from high
school,180 is pregnant,181 lives independently from his or her parents and is financially selfsufficient,182 or is homeless183 may, by virtue of this status, consent to a broad range of
medical interventions.184
No state law permits minors to consent to PrEP therapy or any other pharmacological
HIV prevention modality.185 However, some de facto emancipation exceptions that permit
minors to consent to general medical care coincide with the personal, family, or social
circumstances of certain at-risk minors. At-risk minors who are unaccompanied, have no
contact with or live independently of caregivers, refuse to seek parental consent, or could
endure mental or physical abuse should the provider seek parental consent likely comprise
a great deal of PrEP candidates. Thus, it is critical to consider how state law treats minors
in these circumstances. If a state permits a minor to consent to his or her own general
medical care in these situations, advocates are presented with an excellent opportunity

177 General medical care may include, but is not limited to, care for injuries, illnesses, exams, and sexual
health issues. See General Medical Care, Univ. of Oregon, https://healthcenter.uoregon.edu/Services/
GeneralMedicalCare.aspx [https://perma.cc/UZ6Y-MH3E] (last visited Nov. 20, 2015).
178 See, e.g., Me. Rev. Stat. tit. 22, § 1503 (2015); Mass. Gen. Laws ch. 112, § 12F (2015). See also
Arshagouni, supra note 12, at 334; Hartman, supra note 176, at 422.
179 See, e.g., Ala. Code § 22-8-4 (2015) (“Any minor who . . . is married, or having been married is divorced
. . . may give effective consent to any legally authorized medical, dental, health or mental health services for
himself or herself.”). See also Arshagouni, supra note 12, at 334; Hartman, supra note 176, at 421.
180 See, e.g., Ala. Code § 22-8-4 (“Any minor who . . . has graduated from high school . . . may give
effective consent . . . .”); Hartman, supra note 176, at 421–22.
181 See, e.g., Utah Code Ann. § 78B-3-406 (West 2015) (“[A]ny female regardless of age or marital status,
when given in connection with her pregnancy or childbirth,” may consent). See also Arshagouni, supra note
12, at 334; Hartman, supra note 176, at 421.
182

See infra Part II.A.2.a; Arshagouni, supra note 12, at 334; Hartman, supra note 176, at 422.

183 See, e.g., Ariz. Rev. Stat. Ann. § 44-132 (2015) (“[A]ny emancipated minor, any minor who has
contracted a lawful marriage or any homeless minor may give consent to the furnishing of hospital, medical
and surgical care to such minor . . . ”). See Arshagouni, supra note 12, at 334; Hartman, supra note 176, at 421;
infra Part II.A.2.f.
184

See Arshagouni, supra note 12, at 334.

185

Culp & Caucci, supra note 6, at 120.
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to operationalize PrEP for broad spectrum of high-risk youth who would likely eschew
preventive HIV care in the event that parental consent is required.
By statute, more than half of United States jurisdictions186 permit certain minors
to consent to general medical care, which by implication could include PrEP or other
pharmacological HIV prevention modalities.187 These statutory exceptions to the general
rule that minors may not consent to their own medical care may be divided into six types:
(1) separation and financial independence exceptions; (2) maturity exceptions; (3) midadolescence exceptions; (4) medical necessity exceptions; (5) parental unavailability or
non-engagement exceptions; and (6) homeless youth exceptions.188 Within this framework,
I discuss each, and potential implications for operationalizing PrEP for self-consenting
minors.
a. Separation and Financial Independence Exceptions
At least fifteen jurisdictions have statutes specifying that qualifying minors living
separate and apart from their parents or guardians and “managing their own financial
affairs” may consent on their own behalf to general medical care.189 Some statutes do
186 Unlike the survey of STI consent statutes in this Article, research conducted in connection with de facto
emancipation exceptions should be considered representative and not exhaustive. Additionally, research did
not include a review of the laws of American territories, such as American Samoa, Guam, Puerto Rico, and the
Virgin Islands. Research did not include regulations, state attorney general opinions, or case law.
187 E.g., Ala. Code § 22-8-4 (2015); Alaska Stat. § 25.20.025 (2015); Ariz. Rev. Stat. Ann § 44-132(A);
Ark. Code Ann. § 20-9-602(7) (2015); Cal. Fam. Code § 6922(a) (West 2015); Colo. Rev. Stat. § 13-22103(1)–(2) (2015); Fla. Rev. Stat. § 743.067(3)(b) (2015); Haw. Rev. Stat. §§ 577D-1, 577D-2(a) (2015);
Idaho Code Ann. § 39-4503 (2015); 410 Ill. Comp. Stat. § 210/1.5 (2015); Ind. Code § 16-36-1-3(a)(2)(B)
(i)–(iv) (2015); Kan. Stat. Ann. § 38-123B (2015); Me. Rev. Stat. Ann. tit. 22, § 1503(1) (2015); Md. Code
Ann., Health-Gen. § 20-102(a)(3)(i)–(ii) (West 2015); Mass. Gen. Laws ch. 112, § 12F(v) (2015); Minn. Stat.
§ 144.341 (2015); Miss. Code Ann. § 41-41-3(2) (2015); Mo. Rev. Stat. § 431.056 (2015); Mont. Code Ann.
41-1-402(2) (2015); Nev. Rev. Stat. § 129.030(1)(a) (2015); N.M. Stat. Ann. § 24-7A-6.2 (2015); Okla. Stat.
tit. 63, § 2602(A)(2) (2015); Or. Rev. Stat. § 109.640(2)(a)–(b) (2015); S.C. Code Ann. § 63-5-350 (2015);
S.D. Codified Laws § 20-9-4.2 (2015); Tex. Fam. Code Ann. § 32.003(a)(2)(A)–(B) (West 2015); Wyo. Stat.
Ann. § 14-1-101(b)(iii)–(iv) (2015).
188 There is some overlap between these categories. Alaska, for example, permits minor self-consent to
general medical care if the minor is living separate and apart from his or her parents and is managing his or
her own financial affairs, but also permits consent to general medical care if the parent or guardian cannot
be contacted or the minor patient is unwilling to secure parental consent, as long as the provider counsels
the minor patient as to the interests of the parent “as best as the provider assumes them.” Alaska Stat. §
25.20.025(a)(2) (2015).
189 E.g., Alaska Stat. § 25.20.025; Cal. Fam. Code § 6922(a); Colo. Rev. Stat. § 13-22-103(1)–(2); Ind.
Code § 16-36-1-3(a)(2)(B)(i)–(iv); Me. Rev. Stat. Ann. tit. 22, § 1503(1); Md. Code Ann., Health-Gen. §
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not specify the length of separation and financial independence.190 In these jurisdictions,
the exception may apply not just to those minors with sufficient financial means to
live independently, but also to minors who are homeless, unstably housed, runaways,
castaways, or living on the street, as long as those minors do not currently live with their
parents or guardians and are not reliant upon them for financial assistance. On the other
hand, it is unclear what the language “managing” one’s own “financial affairs” means. Is it
sufficient if the adolescent is currently not receiving financial assistance from a parent or
guardian? What if the unaccompanied minor receives financial assistance from a friend? If
the legislative purpose of these exceptions is to pinpoint a narrow category of minors who
have demonstrated histories of financial responsibility and self-sufficiency, this may run
counter to the argument that homeless, unstably housed, runaway, or castaway youth may
self-consent pursuant to this exception. Advocates, particularly in states that do not have a
dedicated consent law pertaining to homeless youth, should seek clarification about such
laws as they relate to unstably housed youth and consider whether operationalizing PrEP
for unaccompanied, self-consenting youth pursuant to this exception is consistent with its
legislative purpose.
b. Maturity Exceptions: Statutory and Common Law
A minority of United States jurisdictions—including Arkansas, Idaho, Illinois, and
Hawaii—permit minors with sufficient cognitive maturity to consent to general medical
care without the consent of a third party via statute.191 Arkansas, for example, permits
“any unemancipated minor of sufficient intelligence to understand and appreciate the
consequences of the proposed surgical or medical treatment or procedures, [to consent]
for himself or herself.”192 Idaho declares that “[a]ny person who comprehends the need
for, the nature of and the significant risks ordinarily inherent in any contemplated hospital,
20-102(a)(3)(i)–(ii); Mass. Gen. Laws ch. 112, § 12F(v); Minn. Stat. § 144.341; Mo. Rev. Stat. § 431.056;
Mont. Code Ann. §§ 41-1-401(1)(b), 41-1-402(2)(b) (2015); Nev. Rev. Stat. § 129.030(1)(a); N.M. Stat. Ann.
§ 24-7A-6.2(A)(1); Okla. Stat. tit. 63, § 2602(A)(2); Tex. Fam. Code Ann. § 32.003(a)(2)(A)–(B); Wyo. Stat.
Ann. § 14-1-101(b)(iv).
190 See, e.g., Cal. Fam. Code § 6922(a)(2)–(3) (permitting qualifying minors who manage their own financial
affairs to consent without regard to duration or source of income).
191 Ark. Code Ann. § 20-9-602(7); Haw. Rev. Stat. §§ 577D-1, 577D-2(a)(1); Idaho Code Ann. § 394503; 410 Ill. Comp. Stat. § 210/1.5(a)(1) (2015); see generally Moore et al., supra note 6, at 41 (noting that
“[s]ome states have adopted the mature minor doctrine, which permits a minor to consent to or refuse care if it
is established that the minor is mature enough to understand and appreciate the benefits and risks of that care”).
192 Ark. Code Ann. § 20-9-602(7).
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medical, dental, surgical or other health care, treatment or procedure is competent to
consent thereto on his or her own behalf.”193 Illinois permits a minor to consent to general
care if the primary care physician believes the minor understands the risks and benefits, and
is identified as seeking care by a social services agency, attorney, or other adult decision
maker.194
A greater number of United States jurisdictions—including Connecticut, the District
of Columbia, Illinois, Kansas, Maine, Massachusetts, Michigan, Mississippi, Tennessee,
and West Virginia—permit minors with sufficient maturity to consent to general medical
care without parental involvement via common law.195 Under the mature minor doctrine
at common law, the court determines, as a matter of fact, whether the minor has sufficient
cognitive capacity to consent to medical treatment, taking into consideration factors such
as the minor’s age, apparent age, evidence of responsible behavior (outside and inside the
provider setting), and evidence of reasoned decision making.196 In determining whether a
minor had sufficient maturity to consent to care and immunize a provider from liability, the
Tennessee Supreme Court articulated the following test:
193

Idaho Code Ann. § 39-4503.

194

410 Ill. Comp. Stat. § 210/1.5.

195 See Kozup v. Georgetown Univ., 851 F.2d 437, 439 (D.C. Cir. 1988) (recognizing the mature minor
exception in dicta); In re Cassandra C., 112 A.3d 158, 160 (Conn. 2015) (applying mature minor concept
to find provider had not met burden to show seventeen-year-old had sufficient maturity to refuse life-saving
medical treatment); In re E.G., 549 N.E.2d 322, 328 (Ill. 1989) (“[M]ature minor may exercise a common law
right to consent to or refuse medical care . . . .”); In re Swan, 569 A.2d 1202, 1206 (Me. 1990) (finding high
school senior had sufficient maturity to effectuate his “well-formed desires” to order the removal of his feeding
tube); Younts v. St. Francis Hosp. & Sch. of Nursing, 469 P.2d 330, 338 (Kan. 1970) (recognizing doctrine in
context of doctor who performed surgery on finger of seventeen-year-old teenager without parental consent,
as minor “was mature enough to understand the nature and consequences and to knowingly consent to the . . .
[necessary] surgical procedure”); In re Rena, 705 N.E.2d 1155, 1157 (Mass. 1999) (court “consider[s] the
maturity of the child to make an informed choice” in the context of refusal of medical treatment by parent);
Bakker v. Welsh, 108 N.W. 94, 96 (Mich. 1906) (seventeen-year-old could self consent to non-emergency
operation); Gulf & Ship Island R.R. Co. v. Sullivan, 119 So. 501, 502 (Miss. 1928) (finding provider reliance
on consent of seventeen year old who was able to “understand and appreciate” the consequences of vaccination
precluded liability); Cardwell v. Bechtol, 724 S.W.2d 739, 746 (Tenn. 1987); Belcher v. Charleston Area Med.
Ctr., 422 S.E.2d 827, 837–38 (W. Va. 1992) (holding “the mature minor exception is part of the common law
rule of parental consent,” and recognizing the doctrine must be applied in a case-by-case nature). One state—
Pennsylvania—has explicitly rejected the doctrine. See Comm. v. Nixon, 761 A.2d 1151, 1156 (Pa. 2000)
(rejecting in context of a sixteen-year-old adolescent who refused medical intervention), cert. denied, 532 U.S.
1008 (2001).
196 See Cardwell, 724 S.W.2d at 739. See also Thomas A. Jacobs, 2 Children And The Law: Rights &
Obligations § 10.7 (2015).
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[w]hether a minor has the capacity to consent to medical treatment
depends upon the age, ability, experience, education, training, and degree
of maturity or judgment obtained by the minor, as well as upon the conduct
and demeanor of the minor at the time of the incident involved. Moreover,
the totality of the circumstances, the nature of the treatment and its risks or
probable consequences, and the minor’s ability to appreciate the risks and
consequences are to be considered.197
In jurisdictions adopting the mature minor doctrine at common law, providers
seeking to develop policies regarding PrEP for youth should first consider their liability
dimensions in consultation with legal counsel. While common law maturity exceptions
have been affirmed in connection with controversial treatments such as a minor’s right to
refuse lifesaving treatment198 and other prophylaxes such as vaccination,199 PrEP therapy
is neither treatment refusal nor a one-time dosage. In fact, PrEP exposes the youth patient
to enduring risks of side effects and tolerability issues. Moreover, it is unclear how courts
would employ the maturity exception in off-label prescription of Truvada as PrEP for
youth, especially since there is currently little clinical research confirming its safety and
efficacy in the youth population. Thus, even in states with long-established common law
mature minor doctrines, providers should proceed with caution.
In jurisdictions adopting the mature minor doctrine via statute, youth of sufficient
maturity may theoretically consent to their own healthcare, including PrEP, without first
seeking the intervention of a court.200 It is unclear, however, whether these statutes would
require an adjudication that a particular minor is, in fact, sufficiently mature. A provider
who relies on a minor’s consent to PrEP pursuant to a mature minor statute that has not
been the subject of judicial review may only know the statute’s liability dimensions after a
civil or criminal lawsuit is filed against them, or an adverse court ruling is issued.
Notwithstanding these concerns, permitting the physician to assess the competence of
a minor on an individual basis makes sense. It is consistent with recent trends to lower the
age of consent in matters of sexual healthcare and with the highly individualistic nature
197

Cardwell, 724 S.W.2d at 748.

198

E.g., Swan, 569 A.2d at 1206; Rena, 705 N.E.2d at 1157; Cassandra C., 112 A.3d at 160.

199

E.g., Gulf & Ship Island R.R. Co., 119 So. at 502.

200 Maureen Carroll, Transgender Youth, Adolescent Decisionmaking, and Roper v. Simmons, 56 U.C.L.A.
L. Rev. 725, 739–40 (2009).
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of sexual healthcare. Additionally, these exceptions further the important legislative goal
of ensuring adequate healthcare for youth. Furthermore, maturity exceptions that provide
immunity for providers who rely on the self-consent of minors upon a finding of sufficient
maturity incentivize medical professionals to foster substantive conversations with minors
in matters where a minor would sooner forego care altogether than seek the permission of
an adult caregiver.
Thus, while not the surest means of ensuring minor access to PrEP without parental
consent, these exceptions are worthy of future exploration.
c. Mid-Adolescence Exceptions
A small minority of states—for example, Alabama, Kansas, and Oregon—permit
minors to consent to general medical care if they are mid-adolescents.201 These statutory
exceptions set various age minimums. For example, Alabama permits minors fourteen
years of age or older to consent to general medical care.202 Kansas permits minors sixteen
years of age or older to consent to general medical care.203 Oregon permits minors fifteen
years of age and older to consent to general medical care.204 In states with exceptions
permitting mid-adolescents to consent to general medical care, by implication, at-risk midadolescents may consent to pharmacological HIV prevention, including PrEP, without the
consent of a third party.205 Permitting mid-adolescents to self-consent to PrEP pursuant to
201 E.g., Ala. Code § 22-8-4 (2015); Kan. Stat. Ann. § 38-123B (2015); Or. Rev. Stat. § 109.640 (2) (2015).
Common law and state attorney general opinions may also effectively permit minors in mid-adolescence to
consent to general medical care. See, e.g., Cardwell, 724 S.W.2d at 749 (creating a presumption that minors
between age fourteen and eighteen have the capacity to self-consent to medical treatment); Tenn. Op. Att’y
Gen. No. 03-087 (2003) (affirming Cardwell presumption). However, an extensive review of common law and
attorney general opinions is beyond the scope of this Article.
202 Ala. Code § 22-8-4.
203

Kan. Stat. Ann. § 38-123B.

204 Or. Rev. Stat. § 109.640.
205 It is important to acknowledge that these exceptions do not capture youth in early adolescence engaging
in HIV-related risk behavior. This may have a greater impact on minority youth than non-minority youth. For
example, African American youth tend to “engage in sexual behaviors earlier than Caucasians, with significant
sexual pressure beginning in the junior years.” Adolescence: Development During a Global Era 352 (Dena
Phillips Swanson et al. eds., 2010). Additionally, African American youth face an elevated risk of HIV infection.
See id. (noting that African American adolescents comprise sixty-one percent of HIV infections among the age
group despite comprising only fifteen percent of the total adolescent population). Together, these psychosocial
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these exceptions is consistent with the science of adolescent risk-taking, as HIV-related
risk behavior is at its apex during mid-adolescence and is unlikely to be remedied with
traditional HIV prevention methods such as behavioral modification.
d. Medical Necessity Exceptions
Medical necessity exceptions permit minors to consent to general medical care if, in the
provider’s judgment, the service is necessary. Research conducted in connection with this
Article indicates that the only state currently permitting minors to consent to any general
medical care the physician deems necessary is South Carolina.206
By virtue of this broad exception, providers in South Carolina may furnish health
services if the provider determines that care is necessary. However, the statute does not
specify what types of services may be necessary. Nonetheless, for those at-risk youth with
a history of intermittent, improper, or nonuse of condoms or a history of sharing syringes,
a physician may determine that PrEP is, in fact, necessary as a minimum layer of protection
against HIV infection.
South Carolina, which has a greater rate of sexual risk behavior among youth than the
national average,207 is an excellent state for PrEP advocacy among minors. Youth healthcare
advocates in other jurisdictions should consider using South Carolina’s statute as a model
for drafting medical necessity exceptions in their own jurisdictions. Medical necessity
exceptions are legislative reflections of the significant deference courts grant to the treating
physician’s individual assessment of medical necessity in coverage determinations.208
and epidemiological factors indicate that African American youth may need access to effective HIV prevention
earlier.
206 S.C. Code Ann. § 63-5-350 (2015) (“Health services of any kind may be rendered to minors of any age
without the consent of a parent or legal guardian when, in the judgment of a person authorized by law to render
a particular health service, such services are deemed necessary unless such involves an operation . . . .”).
207 For example, South Carolina ranks higher than the national average in the percentage of high-school
students who have had sex (57% and 47%, respectively), almost double the percentage of high school students
who had intercourse for the first time before age thirteen than the national average (11% and 6%, respectively),
higher than the national average in the percentage of high school students who have had sex with more than four
people (21% and 15%, respectively), and higher than the national average in the number of high school students
who consumed drugs or alcohol before their last sexual intercourse (26% and 22%, respectively). U.S. Dep’t
of Health & Hum. Servs., South Carolina Adolescent Reproductive Health Facts 5 (2011), http://www.hhs.
gov/ash/oah/adolescent-health-topics/reproductive-health/states/pdfs/sc.pdf [http://perma.cc/59NN-5TRZ].
208

See Underhill, supra note 3, at 649. For extensive discussion of medical necessity in the context of
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These exceptions touch all aspects of healthcare for minors, and foster active engagement
between patients and physicians.
e. Parental Unavailability or Non-Engagement Exceptions
A minority of states permit medical care to be furnished to minors in the event that a
parent is not “immediately available,” “reasonably available,” or otherwise reachable.209
Alaska’s statute is notable, specifying that:
a minor may give consent for medical and dental services if the parent
or legal guardian . . . cannot be contacted or, if contacted, is unwilling
either to grant or withhold consent; however, where the parent or legal
guardian cannot be contacted or, if contacted, is unwilling either to grant
or to withhold consent, the provider of medical or dental services shall
counsel the minor keeping in mind not only the valid interests of the minor
but also the valid interests of the parent or guardian and the family unit as
best the provider presumes them.210
In Alaska, if an at-risk minor is unable to provide the contact information of an adult
with decision-making authority (for example, if the minor is orphaned or a castaway),
by implication the provider may rely on the consent of the minor to prescribe PrEP upon
considering the purported interests of the minor’s caregiver. It is unclear, however, how a
provider should proceed if a minor refuses to provide the contact information of an adult
decision maker (say, if the minor is a runaway and fears parental retaliation). Clarification
is needed. Additionally, should the minor provide such contact information and the adult
decision maker is unresponsive or declines to either give or refuse consent, the Alaska
statute implies that the physician may rely on the minor’s self-consent to PrEP upon
consideration of the various interests involved.211 Alaska’s statute is also notable in that it
encourages the physician to consider the interests of the parents “as best as the provider
biomedical HIV prevention, see id. at 647–53; Burda, supra note 3, at 203–14.
209 E.g., Alaska Stat. § 25.20.025(a)(2) (2015); Kan. Stat. Ann. § 38-123b (2015); Miss. Code Ann. § 4141-3(2) (2015) (specifying minors age sixteen and older); S.D. Codified Laws § 20-9-4.2 (2015); Wyo. Stat.
Ann. § 14-1-101(b)(iii) (2015); see generally Moore, supra note 6, at 41 (noting that some states “grant minors
general authority to consent to health care when parents are unavailable or unwilling to provide consent or
when the minor is over a particular age threshold”).
210 Alaska Stat. § 25.20.025(a)(2).
211

Id.
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presumes them.” This clause invites speculation by physicians about how parents would
react to the proffered care and shifts the focus from the real interests of the youth before
them to the provider’s imagined interests of absent parents.
Nonetheless, statutory exceptions permitting minors to consent to general medical care
in the event of parental absence, such as Alaska’s statute, may provide an avenue for minor
self-consent to PrEP. Lawmakers in jurisdictions without such exceptions should consider
incorporating these exceptions with careful attention to spotlighting the interests of youth,
considering the actual interests of parents (if articulated), and discouraging speculation
about unconfirmed parental concerns. Furthermore, these exceptions reflect the current
scientific understanding of behavioral changes during adolescence that strain parent-child
relationships. These exceptions also reflect the harsh realities of some marginalized youth
whose parents would sooner bury their heads in the sand than engage with providers about
their child’s unique sexual healthcare needs, or those minors for whom survival depends
upon secrecy.
f. Homeless Youth Exceptions
Homeless youth laws are concerted legislative efforts to serve the healthcare needs of
marginalized youth. Arizona and Florida, for example, explicitly permit homeless youth to
consent to general medical care.212 In its 1991 amendment to the minor consent statute, the
Arizona Legislature added a provision permitting “any homeless minor [to] give consent
to the furnishing of hospital, medical and surgical care to such minor.”213 The statute
defines a homeless minor as an individual under eighteen “living apart from his parents
and who lacks a fixed and regular nighttime residence or whose primary residence is either
a supervised shelter . . . , a halfway house or a place not designed for or ordinarily used
for sleeping by humans.”214 In Arizona, providers serving unstably housed youth at high
risk of HIV infection may be able to rely on the self-consent of those youths to administer
PrEP prevention without regard to the age of the adolescent. On the other hand, given
that PrEP is a comprehensive treatment regimen, the continuation of which requires refill
prescriptions, monitoring, and supervision, it is unclear whether a minor who effectively
consented to PrEP therapy while unstably housed would be able to continue the therapy
without parental involvement if he or she locates more permanent housing mid-therapy. If
continuation of therapy is contingent upon remaining homeless or unstably housed, then
212 Ariz. Rev. Stat. Ann. § 44-132(A) (2015); Fla. Stat. § 743.067(3)(b) (2015).
213 Ariz. Rev. Stat. Ann. § 44-132(A).
214

Id.
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furnishing PrEP to runaway or castaway youth who value continuing it could actually
disincentivize them from seeking stable housing and reconciliation with parents, guardians,
or adult caregivers. It is possible that Arizona legislators could remedy this uncertainty by
amending its existing statute.
Apart from this uncertainty, Arizona’s statute may be seen as a model for other states
considering how to better meet the privacy and healthcare concerns of marginalized, often
invisible youth. Lawmakers in jurisdictions with the greatest shares of homeless youth—
most notably California215—should consider amending existing consent statutes to add
this exception. This, in turn, could enable confidential access to the full range of HIV
prevention methods for a great number of unstably housed, at-risk youth.
h. Putting the Framework into Action
This exercise of disaggregating de facto emancipation exceptions that permit minors to
consent to general medical care and grouping them by personal, family, and social circumstance is a useful tool for advocates and policymakers considering whether their state statutes
meet the privacy needs of at-risk minors in sensitive healthcare matters. It also provides an
advocacy framework for those considering potential avenues to operationalizing PrEP and
other pharmacological prevention modalities for at-risk minors without parental consent.
Disaggregating these exceptions can help eliminate confusion and inaccuracies. In fact, one
recent, peer-reviewed study of laws permitting minor consent to general medical care that
aggregated de facto emancipation exceptions216 was both under-inclusive and inaccurate.217
215 As of 2013, the U.S. Department of Housing and Urban Development (HUD) estimated that California
had the highest number of unaccompanied homeless youth (UHY), with more than four times the number
of UHY than New York (n=15,469, n=3,670). See U.S. Dep’t of Housing & Urban Dev., Annual Homeless
Assessment Report (AHAR) to Congress 49 (2013), https://www.hudexchange.info/resources/documents/
ahar-2013-part1.pdf [http://perma.cc/44V8-W4TU].
216 See, e.g., Doriane Lamberlet & Phillip Rosoff, The Legal Authority of Mature Minors to Consent to
General Medical Treatment, 131 Pediatrics 786, 790–91 Tbl.1 (2013), http://pediatrics.aappublications.org/
content/131/4/786.full.pdf [http://perma.cc/MWZ6-TS76] (aggregating mid-adolescence exceptions, parental
unavailability exceptions, emergency exceptions, mature minor case law, and attorney general opinions).
217 Lamberlet and Rosoff’s 2013 study published in Pediatrics was both under-inclusive and imprecisely
conveyed the scope of care to which a minor may consent. Compare id. at Tbl.1 with Tbls.1–3, infra at 359–64.
For example, pursuant to Delaware’s emergency exception, minors may only consent, after reasonable efforts
to secure the consent of a parent or guardian, to specific care: treatment of traumatic injury and treatment
of a “symptom, disease or pathology which may, in the judgment of the attending personnel preparing such
treatment, if untreated, reasonably be expected to threaten the health or life of such minor.” Del. Code Ann.
tit. 13, § 707(b)(5) (West 2015). However, Lamberlet and Rosoff represented Delaware’s statute as permitting
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Thus, further reviews of state emancipation statutes based on this framework are needed.
As I concluded with respect to the survey of STI consent statutes herein, what this
exercise also reveals is a deep discord among the states about confidential access to care
for minors. This discord, along with provider confusion that can result in the delay of
critical healthcare services, are justifications for the development of federal solutions that
set national policies on confidential access to care for minors.218
3. Furnishing PrEP Pursuant to Emergency Exceptions
In addition to state exceptions permitting minors to consent to general medical care,
there are a number of state exceptions permitting physicians to act without parental consent
in more limited scenarios. One of these scenarios is the emergency. Almost all states
“recognize the need for medical professionals to render emergency treatment to minors free
from the specter of civil liability for failure to obtain informed consent from parents,”219
either by common law or enacted law.220 This exception to the general rule that minors
may not consent to their own medical care is service-specific, applying only to treatment
in connection with emergencies. This is unlike emancipation exceptions, which apply to
general medical care. Emergency exceptions are also unlike emancipation exceptions,
which typically give certain minors adult capacity, because emergency exceptions do not
grant the minor these rights. In exigent circumstances, parental consent is implied.221
The majority of United States jurisdictions have statutes specifically pertaining to
minor consent to general medical care, which is inaccurate. In Delaware, care may only be offered in connection
with a specific injury or “symptom, disease or pathology.” This could cause provider confusion about a minor’s
ability to consent to prophylactic care, which does not exist to treat a specific injury, symptom, or disease, but
rather exists to prevent it.
218 See Hartman, supra note 176, at 426 (advocating for “[f]ederal legislation to establish a unified, national
policy regarding adolescent decision-making capability” and observing that “by recognizing decision-making
ability of adolescents, the policy would be responsive to the reality of adolescent cognitive development and to
the particular needs of adolescents, separate and apart from younger children”).
219

Jacobs, supra note 196, at § 10.5.

220 Research conducted in connection with statutory emergency exceptions should be considered representative and not exhaustive. Regulations cited herein should also be considered representative. Additionally, I
did not review the common law dimensions of emergency treatment of minors without parental consent.
221 See Richard W.O. Beebe & Debora L. Funk, Fundamentals of Emergency Care 36 (2001) (noting that
“in . . . emergent cases, the law assumes that the parents would want their seriously ill or injured child to be
treated [, and] [s]uch treatment would be possible under implied consent”).
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emergency treatment of minors.222 Among the fifty states (and the District of Columbia),
there exist two types of statutory emergency exceptions: broad and narrow. Both broad and
narrow statutory exceptions remove the consent requirement and are silent as to whether the
minor may self-consent in these situations.223 Additionally, both include three dimensions:
(1) the severity of the injury and/or the potential effect of delaying care; (2) who may
provide services; and (3) the type of care that can be rendered.
In this section, I consider each of these dimensions in broad and narrow emergency
exceptions. I apply the two types of exceptions to minor consent to PrEP and argue that,
in states with broad emergency exceptions, it would be possible to frame PrEP as an
emergency. I introduce the concept of a “PEP to PrEP pipeline,” the idea that an at-risk
minor who believes he or she was exposed to HIV may be treated with post-exposure
prophylaxis (PEP), a thirty day course of ARV treatment (which could include Truvada),
under the emergency exception without securing parental consent. After the thirty-day
course of supervised PEP treatment, medical documentation of tolerability, and confirmation
of HIV-negative status, the option of continuing treatment with Truvada as PrEP may be
swiftly introduced.
The first dimension of statutory emergency exceptions is a limitation on the nature
and severity of the medical issue. In jurisdictions with broad statutory definitions of the
medical dimension, a provider may furnish emergency care if the life or health of the minor
is in peril. In the District of Columbia, for example, a licensed physician or dentist may
provide “health services” to a minor of any age without parental consent if the provider
determines that “the delay that would result from attempting to obtain parental consent
would substantially increase the risk to the minor’s life, health, mental health, or welfare,
or would unduly prolong suffering.”224 This exception does not specify the nature of injury
for which emergency services are sought. Rather, the provider may furnish care if he or she
believes that seeking parental consent would have the effect of “substantially” elevating
the risk to the minor’s wellbeing, with respect to “life, health, mental health, or welfare.”225
The District of Columbia regulation implies that a provider could furnish PrEP if there is a
major chance (or the provider is certain) that the minor will be exposed to HIV during the
222 According to research conducted for this Article, states with no statutory emergency exception include
Hawaii, Idaho, Indiana, Iowa, Kansas, Maine, Michigan, Ohio, Oregon, Rhode Island, Texas, Utah, Vermont,
Washington, Wisconsin, and Wyoming.
223

See Jacobs, supra note 196, at § 10.5.

224

D.C. Mun. Regs. tit. 22-B, § 600.4 (2015).

225

Id. (emphasis added).
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delay caused by seeking parental consent, or if there is a major chance (or the provider is
certain) that the minor will experience violence or disownment should the provider notify
parents and “out” him or her.226 In jurisdictions with broad injury dimensions such as this,227
226

Consultation of case law would be necessary.

227 Ala. Code § 22-8-3 (2015) (“Any legally authorized medical, dental, health or mental health services
may be rendered to minors of any age without the consent of a parent or legal guardian when, in the physician’s
judgment, an attempt to secure consent would result in delay of treatment which would increase the risk to the
minor’s life, health or mental health.”); Conn. Gen. Stat. § 17a-81(a) (2015) (“In the event [parental] consent is
withheld or immediately unavailable and the physician concludes that treatment is necessary to prevent serious
harm to the child, such emergency treatment may be administered pending receipt of parental consent.”); Ga.
Code Ann. § 31-9-3 (a)(2) (West 2015) (providing an exception for when “a person authorized to consent [for
a minor] is not readily available and any delay in treatment could reasonably be expected to jeopardize the life
or health of the person affected or could reasonably result in disfigurement or impaired faculties”); Ky. Rev.
Stat. Ann. § 214.185(4) (West 2015) (“Medical, dental, and other health services may be rendered to minors
of any age without the consent of a parent or legal guardian when, in the professional’s judgment, the risk to
the minor’s life or health is of such a nature that treatment should be given without delay and the requirement
of consent would result in delay or denial of treatment.”); Md. Code Ann., Health‐Gen. § 20‐102(b) (West
2015) (“A minor has the same capacity as an adult to consent to medical treatment if, in the judgment of the
attending physician, the life or health of the minor would be affected adversely by delaying treatment to obtain
the consent of another individual.”); Minn. Stat. § 144.344 (2015) (“Medical, dental, mental and other health
services may be rendered to minors of any age without the consent of a parent or legal guardian when, in the
professional’s judgment, the risk to the minor’s life or health is of such a nature that treatment should be given
without delay and the requirement of consent would result in delay or denial of treatment.”); Nev. Rev. Stat. §
129.030(1)(d) (2015) (“In a physician’s judgment, in danger of suffering a serious health hazard if health care
services are not provided.”); N.Y. Pub. Health Law § 2504(4) (McKinney 2015) (“Medical, dental, health and
hospital services may be rendered to persons of any age without the consent of a parent or legal guardian when,
in the physician’s judgment an emergency exists and the person is in immediate need of medical attention and
an attempt to secure consent would result in delay of treatment which would increase the risk to the person’s
life or health.”); Okla. Stat. Ann. tit. 63 § 2602.7 (West 2015) (“Any minor in need of emergency services for
conditions which will endanger his health or life if delay would result by obtaining consent from his spouse,
parent or legal guardian.”); 35 Pa. Cons. Stat. § 10104 (2015) (“Medical, dental and health services may
be rendered to minors of any age without the consent of a parent or legal guardian when, in the physician’s
judgment, an attempt to secure consent would result in delay of treatment which would increase the risk to the
minor’s life or health.”); S.C. Code Ann. § 63-5-350 (2015) (“Health services . . . may be rendered to minors
of any age without the consent of a parent or legal guardian when, in the judgment of a person authorized by
law to render a particular health service, such services are deemed necessary unless such involves an operation
which shall be performed only if such is essential to the health or life of such child . . . .”); S.D. Codified Laws §
20-9-4.2 (2015) (“A minor . . . may be treated by a licensed physician before the minor’s parent’s or guardian’s
consent is obtained if a parent or guardian is not immediately available and if, in the opinion of the treating
physician . . . , the attempt to secure the consent would result in delay of treatment which would threaten
the minor’s life or health.”); Tenn. Code Ann. § 63-6-222(a) (2015) (“Any licensed physician may perform
emergency medical or surgical treatment on a minor, despite the absence of parental consent or court order,
where such physician has a good faith belief that delay in rendering emergency care would, to a reasonable
degree of medical certainty, result in a serious threat to the life of the minor or a serious worsening of such
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a provider could furnish care in a range of harm reduction scenarios, including PrEP, where
in the event of delay, the risk of serious harm to the minor’s wellbeing is substantial.228
On the other hand, jurisdictions that narrowly define the nature and scope of the
emergency typically limit the exception to scenarios where the minor is suffering from a
material and morbid illness, disease, pathology, or condition,229 and when death or serious
injury is imminent.230 Because narrow emergency exceptions specify that care must be
administered in connection with a condition, illness, injury, or disease, by implication,
treatment in connection with preventing a condition, illness, injury, or disease falls
outside the scope of emergency exceptions with narrow injury dimensions.231 When care
is furnished in connection with an illness that has not yet occurred or when the patient is
asymptomatic, the patient cannot be said to be suffering from any present condition. Thus,
advocates may have more difficulty operationalizing PrEP—prescribed to asymptomatic,
HIV-negative individuals—for minors pursuant to emergency exceptions with narrow
minor’s medical condition and that such emergency treatment is necessary to save the minor’s life or prevent
further deterioration of the minor’s condition.”).
228 Unlike other jurisdictions with broad injury dimensions, in the District of Columbia, an argument may
be made that if, in the physician’s judgment, the attempt to secure consent would likely result in physical or
emotional abuse or violence by a third party, the provider may render services without consent. This is useful
in the case of child abuse, endangerment, and neglect.
229

E.g., Del. Code Ann. tit. 13, § 707(b)(5) (West 2015):
Consent . . . may be given by . . . [a] minor . . . for the examination and treatment of (i) any
laceration, fracture or other traumatic injury suffered by such minor, or (ii) any symptom,
disease or pathology which may, in the judgment of the attending personnel preparing such
treatment, if untreated, reasonably be expected to threaten the health or life of such minor;
provided, however, that the consent given shall be effective only after reasonable efforts
shall have been made to obtain the consent of the parent or guardian of said minor.

230 E.g., Mo. Rev. Stat. § 431.063 (2015) (“For the purposes hereof, an emergency is defined as a situation
wherein, in competent medical judgment, the proposed surgical or medical treatment or procedures are
immediately or imminently necessary and any delay occasioned by an attempt to obtain a consent would
reasonably jeopardize the life, health or limb of the person affected, or would reasonably result in disfigurement
or impairment of faculties.”); Mont. Code Ann. § 41-1-405 (1) (2015) (“A health professional may render or
attempt to render emergency service or first aid, medical, surgical, dental, or psychiatric treatment, without
compensation, to any injured person or any person regardless of age who is in need of immediate health care
when, in good faith, the professional believes that the giving of aid is the only alternative to probable death or
serious physical or mental damage.”); N.C. Gen. Stat. Ann. § 90-21.1(4) (West 2015) (“necessary to prevent
immediate harm to the child”).
231 See generally Burda, supra note 3, at 207–08 (investigating this issue in the context of insurance benefit
denials).
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injury dimensions.232
However, if a provider diagnoses the minor with “exposure to HIV,” this may permit
the provider to furnish Truvada as PEP (as opposed to PrEP) without parental consent. In
the event a minor is actually exposed to HIV (e.g., if the minor has condomless, receptive
anal sex with a known HIV-positive, virally unsuppressed partner) or is likely exposed
to HIV (e.g., if the minor has condomless, receptive anal sex with a partner in a high
HIV prevalence group of unknown status), PEP should administered within seventy-two
hours to avoid potential infection. Given the significant risk of delaying PEP, administering
Truvada as PEP may fall within the scope of the injury dimension of emergency exceptions.
As such, a potential avenue for PrEP access is to begin treatment as PEP and then convert
treatment to PrEP.233 Thus, even if a jurisdiction’s emergency exception has a narrow injury
dimension, it may be possible to use the exception as a means to deliver confidential PrEP
232 Whether the injury dimension would permit minor access to PrEP without express parental consent
is refined by case law. Courts appear more likely to find that a scenario is an emergency, warranting bypass
of parental consent, if the delay in care caused by securing parental consent would likely result in imminent
serious harm or death. See Tabor v. Scobee, 254 S.W.2d 474, 477 (Ky. 1951) (despite eventual effect of delaying
removal of fallopian tubes could have been death within six months, death was not imminently likely). But
see Piedra v. Dugan, 123 Cal. App. 4th 1483, 1491 (Cal. Ct. App. 2004) (treatment of infant’s prolonged
seizure without parental consent seizure justified as emergency); Luka v. Lowrie, 136 N.W. 1106, 1109 (Mich.
1912) (instant amputation was necessary to preserve life for fifteen-year-old boy). In interpreting its own
emergency exception, the Supreme Court of Texas stated the following about the severity of the condition: “[T]
he emergent circumstances exception acknowledges that the harm from failing to treat outweighs any harm
threatened by the proposed treatment . . . because the harm from failing to provide life-sustaining treatment
under emergent circumstances is death.” Miller ex rel. Miller v. HCA, Inc., 118 S.W.3d 758, 768 (Tex. 2003).
California has a broader test for whether an emergency exists. The court asks “whether the undisputed facts
establish the existence of an exigency of ‘so pressing a character that some kind of action must be taken.’”
Bryant v. Bakshandeh, 226 Cal. App. 3d 1241, 1247 (Cal. Ct. App. 1991) (quoting Kearns v. Super. Court, 204
Cal. App. 3d 1325, 1328 (Cal. Ct. App. 1988)). This suggests that determining whether an emergency exists
involves a balancing test. Parental consent may be implied pursuant to emergency exceptions if the risk of
serious harm or death caused by delaying care to secure parental consent is greater than the risk of the care
itself. Applying this test to PrEP for minors, the risk of serious harm to the minor (HIV infection) caused by
delaying therapy may not outweigh the risk of prescription of Truvada as PrEP because, while failing to provide
PrEP to the minor may eventually lead to HIV infection, infection is not the imminent, probable consequence.
Additionally, given that PrEP is administered in perpetuity, the risks inherent in the therapy are ongoing and
not singular in their occurrence.
233 However, there are a number of questions about the implications of continuing PEP as PrEP. For example,
must the provider seek consent from a parental figure once Truvada is continued as PrEP? Is the consent of
a parent figure required as a result of the addition of the periodic monitoring, testing, and refill prescriptions
required when the limited course of PEP treatment turns into the continuous therapy of PrEP? Is a new coded
diagnosis required at all?
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access to youth.
While the first dimension of emergency is nuanced, the second dimension of statutory
emergency exceptions is less so. Emergency exceptions also include a limitation on who
may provide emergency treatment to the minor.234 Jurisdictions with broad caregiver
dimensions permit a broad range of healthcare professionals to furnish care.235 This may
be interpreted as including advanced practice nurses, emergency medical technicians,
physician’s assistants, and other non-physician healthcare workers. Conversely,
jurisdictions with narrow caregiver dimensions limit those professionals who may furnish
care to physicians,236 and some include dentists and surgeons.237 While the caregiver
dimension involves little interpretation, it is important to consider its implications for PrEP.
Some providers serving at-risk youth may be staffed solely by advance practice nurses who
may prescribe PrEP but may nonetheless be unable to provide services according to this
exception should the jurisdiction limit those who may act to licensed physicians.
The third dimension of statutory emergency exceptions is a limitation on the type
of care that can be furnished.238 Broader statutes define these services in an expansive

234 This dimension lacks a common law layer.
235

See, e.g., Minn. Stat. § 144.344 (2015):
Medical, dental, mental and other health services may be rendered to minors of any age
without the consent of a parent or legal guardian when, in the professional’s judgment, the
risk to the minor’s life or health is of such a nature that treatment should be given without
delay and the requirement of consent would result in delay or denial of treatment.

(emphasis added).
236 See, e.g., Md. Code Ann., Health Gen. § 20-102(b) (West 2015) (“in the judgment of the attending
physician”); Nev. Rev. Stat. § 129.030(1)(d) (2015) (“physician’s judgment”); N.Y. Pub. Health Law §
2504(4) (McKinney 2015) (“in the physician’s judgment”).
237

E.g., D.C. Mun. Regs. tit. 22-B, § 600.4 (2015).

238 Courts interpreting emergency exceptions tend to specify that the standard of care administered in such
situations is “that which the occasion demands within the usual and customary practice among physicians in
the same locality.” See Sullivan v. Montgomery, 279 N.Y.S. 575, 577 (N.Y.C. Civ. Ct. 1935). Accord Wheeler
v. Barker, 208 P.2d 68, 71 (Cal. Ct. App. 1949); Jackovach v. Yocom, 237 N.W. 444, 449 (Iowa 1931). But
cf. Rogers v. Sells, 61 P.2d 1018, 1019 (Okla. 1936) (accepting testimony of medical expert that appropriate
course of action for physicians confronted with leg fracture is not amputation when main blood vessel is not
destroyed).
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manner, specifying that “health services” can be furnished.239 Narrower emergency
exceptions specify that “treatment,” “medical treatment,” or “surgical treatment” can be
furnished.240 PrEP therapy may readily be considered a health service in jurisdictions with
broad care dimensions. On the other hand, if a jurisdiction limits the type of care to medical
“treatment,” whether PrEP may be furnished could depend on whether PrEP is considered
a treatment.241
An analysis of each of these dimensions of emergency exceptions reveals that, while it
may be theoretically possible to frame PrEP therapy as an emergency and thereby bypass
parental consent, there are a number of uncertainties to explore before doing so.242 Providers
239 E.g., Ala. Code § 22-8-3 (2015) (“[a]ny legally authorized medical, dental, health or mental health
services”); Cal. Bus. & Prof’l Code § 2397(c)(2) (West 2015) (“requiring immediate services”); Minn. Stat. §
144.344 (“[m]edical, dental, mental and other health services”); Nev. Rev. Stat. § 129.030(1)(d) (“health care
services”); N.Y. Pub. Health Law § 2504(4) (“[m]edical, dental, health and hospital services”); 35 Pa. Cons.
Stat. § 10104 (“[m]edical, dental and health services”).
240 Md. Code Ann., Health-Gen. § 20-102(b) (“medical treatment”); Tenn. Code § 63-6-222(a) (2015)
(“emergency medical or surgical treatment”).
241

See Culp & Caucci, supra note 6, at 122.

242 In addition to the uncertainties I have raised with respect to these three dimensions, it would be critical
to consider the liability dimension of emergency exceptions. Jurisdictions with narrower immunity provisions
provide immunity for civil penalties that arise solely because the minor did not have capacity. See, e.g., W.
Va. Code Ann. § 60A-5-504 (West 2015) (“No emergency medical service personnel may be subject to civil
liability, based solely upon failure to obtain consent in rendering emergency medical services to any individual
regardless of age where the patient is unable to give his or her consent for any reason.”). Jurisdictions with
broader immunity provisions shelter providers from criminal and licensing body disciplinary penalties that
arise solely because the minor lacked the capacity to consent. See, e.g., Md. Code Ann., Health-Gen. § 20102(e) (West 2015) (“A licensed health care practitioner who treats a minor is not liable for civil damages or
subject to any criminal or disciplinary penalty solely because the minor did not have capacity to consent under
this section.”). In the context of PrEP, it would be important for providers to carefully review the immunity
dimension of the state’s emergency exception, with attention to case law, in light the range of potential civil
claim or criminal charges that could be brought against providers who furnish PrEP pursuant to the emergency
exception without parental consent. In addition to criminal liability for battery and assault, providers should
consider whether their jurisdiction has a criminal statute pertaining to contributing to the delinquency of a
minor and whether providers could be liable under such a statute for furnishing PrEP. Consider the following
statement of immunity from regulations of the District of Columbia:
Any minor who is examined, treated, hospitalized, or receives health services under this
chapter may give legal consent, and no person who administers the health services shall be
liable civilly or criminally for assault, battery, or assault and battery; or any other civil legal
charge, except for negligence or intentional harm in the diagnosis and treatment rendered
to the minor . . . .

30.2

Columbia Journal of Gender and Law

349

should first consider each of the dimensions of their state’s emergency exception, determine
whether the statute is broad or narrow, further review state regulations pertaining to the
consent of minors in emergencies and case law interpretations of those exceptions, and
examine any parental notification requirements.243 As I have indicated in the framework
above, providers in states with broader emergency exceptions may have more success in
furnishing care thereunder than providers in states with narrower exceptions. Additionally,
lawmakers should consider amending emergency exceptions to include prophylactic
treatment for exposure to STIs, which would more clearly permit prescription of PEP
without express parental consent. This furthers the public interests of securing the personal
health of minors in high-prevalence groups and eliminating fear of liability that could
result in delays in care. This could have secondary effects on operationalizing PrEP for
self-consenting minors, as PrEP applications could lead to PrEP applications.244
a. State Parental Notification Laws
In addition to considering whether minors may consent to PrEP under state statutory
exceptions, it is also necessary to consider whether providers are required to notify parents
pursuant to state statute if a minor seeks PrEP therapy.245 With respect to notification in
D.C. Mun. Regs. tit. 22-B, § 602.4 (2015). In this jurisdiction, a plain reading of the regulation indicates that
a provider would be immune from civil liability and certain criminal charges—specifically, assault and/or
battery—for providing medical services pursuant to the emergency exception. However, by specifying assault
and battery, the legislature has left open the question of whether a provider could be charged under another
criminal statute.
243 See, e.g., Okla. Stat. Ann. tit. 63, § 2602(7)(b) (West 2015) (specifying that “[t]he health professional
shall be required to make a reasonable attempt to inform the . . . parent or legal guardian of the minor of any
treatment needed or provided” under the emergency exception).
244 On the other hand, it is worth considering any negative effects that could result from seeking PrEP for
self-consenting minors under emergency exceptions. First, because the emergency exception merely implies
consent of the parent, conditioning access to PrEP on an emergency exception does not recognize the authority
of minors to consent in sexual healthcare matters. Thus, it does not advance the cause of empowering youth to
make decisions about protecting their own sexual health. Second, characterizing an at-risk minor’s situation as
an emergency requiring immediate intervention may further marginalize them and stigmatize their behavior.
Relying on an emergency exception invites an inquiry into how desperate the minor’s situation really is.
Furnishing PrEP according to an emergency exception also invites a provider to paint the minor as having
a desperate situation, which stigmatizes, even pathologizes their behavior. Thus, the goal of enabling at-risk
minors to consent to pharmacological HIV prevention may be better achieved through other state and federal
means.
245 Consideration of parental notification requirements in administrative and common law is beyond the
scope of this Article.
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connection with STI services, a 2015 survey by the Guttmacher Institute of state STI laws in
United States jurisdictions (including the District of Columbia and excluding United States
territories) found that no jurisdiction mandates that providers contact parents regarding
STI issues.246 However, eighteen United States jurisdictions expressly or impliedly permit
the physician to notify the parent.247 Statutes permitting parental notification have the
potential to create inconsistent policies among providers and dissuade some youth from
seeking care. The mere request for information concerning the existence of caregivers,
their whereabouts, or the minor’s relationship to them could make it more difficult to reach
marginalized, at-risk minors.
Additionally, even though providers are not obligated to notify the parent of a
minor’s request for STI care, insurers regularly do notify parents of any requests. Broadly
used insurance claims processing and billing practices such as explanation of benefit
(EOB) paperwork transmitted to policyholders after care is provided “routinely violate
confidentiality for everyone, often a minor or a young adult, insured as a dependent.”248
One 2012 survey of state laws related to confidentiality for dependents concluded that
“virtually all states requir[e] notices when claims are denied,” and about fifty percent of the
states “either require or presume the sending of an EOB.”249 Because many youth would
prefer to eschew sexual healthcare entirely rather than notify their parents of their intent
to seek such care, addressing these breaches of confidentiality on the insurance side will
be critical to operationalizing PrEP among youth, particularly if insurers begin to deny
coverage requests for PrEP. One potential advocacy solution with respect to EOBs sent
246 See Guttmacher Inst., State Policies in Brief: Minors’ Access to STI Services (2015), http://www.
guttmacher.org/statecenter/spibs/spib_MASS.pdf [http://perma.cc/BF88-3H82].
247 See id. While no United States jurisdiction mandates parental notification about STI-related care, some
jurisdictions mandate parental notification in connection with care rendered pursuant to emergency exceptions.
For example, North Dakota’s emergency exception requires that physicians take “reasonable steps” to notify
adult caregivers before providing emergency services to minors or care to minors who are victims of sexual
assault. N.D. Cent. Code § 14-10-17.1(2) (2015). In the context of an emergency, when parental consent is
implied, requiring the provider to take steps to seek express consent from an adult caregiver is logical. However,
in its application to pharmacological HIV prevention, parental notification for PEP or PrEP administered to a
minor pursuant to the emergency exception is problematic, as a minor who has been exposed to HIV or at risk
of exposure may eschew medically necessary care if it is conditioned on parental notification. This is another
reason why operationalizing pharmacological HIV prevention for minors is troublesome under emergency
exceptions.
248 Abigail English et al., Confidentiality for Individuals Insured as Dependents: A Review of State
Laws and Policies 1 (2012), https://www.guttmacher.org/pubs/confidentiality-review.pdf [https://perma.cc/
BB32-FV5T].
249

Id.
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in connection with requests for PrEP would be the development of state regulations that
permit the patient to specify an address to which the insurer may send the EOB.250 This
would permit minor patients to designate a third party, such as a youth center, to receive the
EOB on their behalf. A second potential solution is a federal regulatory mandate requiring
insurers to adhere to generic EOBs on parents’ insurance. Such a regulation could require
insurers to omit all specifics in matters involving minors and concerning sexual healthcare
and addiction, generally, or STI services, specifically. This federal solution could give
“teeth” to agreements between state policymakers and individual insurers that require
insurers to adhere to generic EOBs.251
Multiple barriers to confidential access to PrEP for minors—at the parental level
(through parental consent requirements), the provider level (through statutes permitting
parental notification), and the insurer level (through common industry practices)—stand
between at-risk youth and effective HIV prevention. This is a worthy justification for
permitting confidential access to PrEP in federally funded programs that ensure confidential
care for minors.
b. Title X
Though there may be a number of different solutions to ensuring confidential access
to pharmacological HIV prevention for at-risk minors, one potential solution to both
the parental consent and parental notification dimensions is the Title X Family Planning
Program.252 Title X, also known as the “Population Research and Voluntary Family Planning
Programs,”253 is the only grant-maker at the federal level “dedicated solely to providing
individuals with comprehensive family plan and related preventive health services.”254

250 See generally id. at 18 (recommending that one approach “is to send EOBs for sensitive services only to
the patient using whichever address or means of communication the patient specifies”).
251 In Rhode Island, for example, one state official contacted insurers directly and had insurers agree to the
following: “because of [the State’s] ability to test and treat STIs and HIV in adolescent populations without
parental consent, the insurer must, under strict confidentiality codes, adhere to a generic EOB on the parent’s
insurance.” E-mail from Paul Loberti, Adm’r, Exec. Office of Health & Human Servs., Medicaid Div. HIV
Provision of Care, to Jason Potter Burda (Sept. 27, 2015, 15:50 EST) (on file with author).
252 This solution was suggested by Culp and Caucci, supra note 6, at 123.
253

Family Planning Services and Population Research Act of 1970, Pub. L. No. 91-572, 84 Stat. 1504.

254 Title X Family Planning, U.S. Dep’t of Health & Hum. Servs., http://www.hhs.gov/opa/title-x-familyplanning [http://perma.cc/FEK2-9STK] (last visited July 6, 2015) [hereinafter Title X Family Planning].
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Under Title X and the regulations enforcing it,255 family planning clinics administered
through state and local health departments, hospitals, schools, and non-profits receiving
Title X funding must ensure that services are confidential.256 Title X clinics provide a broad
range of services, including contraceptives, counseling, pregnancy testing, screening and
treatment for STIs, and HIV testing.257 As of 2012, over 4,000 clinics across the country
received Title X funds.258 Because all clinics must provide confidential services, receipt of
services cannot be conditioned upon parental consent or notification.
If clinics receiving Title X funds offered PrEP, minors receiving such care could
potentially self-consent to PrEP therapy without fear that the provider might notify his or
her parents. Offering PrEP in Title X clinics also fits well with the services these clinics
already offer. In 2012, Title X clinics conducted approximately 1.3 million HIV tests on
men and women.259 Further investigation into the cost effectiveness of offering PrEP in the
family planning context will be critical. In that regard, it will be important to focus on the
cost savings to the government in HIV infections (and a lifetime of treatment) averted as a
result of offering confidential access to PrEP on a broad scale.260 For clinics who decide to
take Title X funds, further clarification from HHS that grant funds may be used for services
related to PrEP and whether HHS would need to amend its rules and/or grant availability
notices, may also be required.
Ensuring that youth have confidential access to PrEP will require holistic solutions
at both the state and federal levels. While attaching PrEP to Title X clinics could make
confidential PrEP therapy accessible to thousands of at-risk youth across the country who
seek their healthcare through such providers, state solutions are also needed to ensure
confidential PrEP access for at-risk youth who seek HIV prevention services through
individual primary care physicians, advanced care nurses, state public health departments,
or hospitals. To that end, the frameworks I have developed and the state-level survey
herein are an excellent starting point for advocates, policymakers, and state lawmakers
255

Public Health Service Act, 42 U.S.C. § 300(a) (2012); 42 C.F.R. § 59.5(a) (2015).

256

42 U.S.C. § 300ff-61(a) (2012).

257 Title X Family Planning, supra note 252.
258

Id.

259 Id. (citing C.I. Fowler
(2014)).

et al.,

RTI Int’l, Family Planning Annual Report: 2011 National Summary

260 See id. (discussing cost savings to taxpayers in the contraception context and the additional savings from
STI treatment averted through prevention efforts).
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who recognize the importance of ensuring that at-risk youth have access to the most
effective HIV prevention method for them without fear of parental judgment, obstruction,
disownment, or violence.
III. Ensuring PrEP Acceptability Within Sexual Education
In addition to developing solutions that guarantee confidential access to PrEP for
youth, advocates must also address the issue of acceptability of PrEP. Put another way,
assuming that minors can consent to PrEP therapy without parental involvement, the next
issue is whether minors will actually want to consent to PrEP. According to one PrEP
activist, there is a perception that people who use PrEP are “very, very slutty.”261 Ensuring
PrEP acceptability among youth requires eliminating the stigma that attaches to those who
use it. Doing so is best achieved through education that places PrEP alongside other longestablished HIV prevention methods such as behavioral modification, risk reduction, and
condoms. As I discussed in Part I, the major loci of HIV prevention education for youth
are in-school sexual education programs. In this section, I explore state and federal means
of ensuring that schools include accurate and complete information about PrEP in their
curricula. To that end, in Part A, I develop advocacy suggestions at the local and state
levels, and in Part B, I explore the potential of attaching PrEP education to grants funded
by HHS’ Personal Responsibility Education Program, which touches thousands of public
schools nationwide.
A. Local and State Advocacy
State statutes that require schools to include education about STIs may provide a
starting point for state and local advocates seeking inclusion of PrEP information in sex
education curricula. Most jurisdictions have statutes that mandate school-based instruction
on STIs and HIV.262 Some leave the content of instruction up to local school districts.263 As
261 Burda, supra note 3, at 193 (citing Mark Joseph Stern, “I Have Learned Not to Underestimate the Stigma”:
Peter Staley on Truvada, Condoms, and HIV Prevention, Slate (May 22, 2014, 9:00 AM), http://www.slate.com/
blogs/outward/2014/05/22/peter_staley_talks_about_truvada_hiv_and_stigma.html [http://perma.cc/WV698LKR]).
262 See Matthew Lashof-Sullivan, Sex Education in Schools, 16 Geo. J. Gender & L. 263, 264 n.1 (2015)
(listing jurisdictions mandating STI instruction in public schools). A survey of state statutes pertaining to HIV
education in schools is beyond the scope of this Article.
263 See, e.g., Conn. Gen. Stat. Ann., § 10-19 (b) (West 2015) (requiring inclusion of “systematic instruction
on [AIDS]” but delegating “[t]he content and scheduling of the instruction” to “the local or regional board of
education”).
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such, advocates at the local level can play a role in encouraging individual school districts
to include PrEP in HIV prevention instruction. However, other jurisdictions specify the
exact requirements of programs. For example, North Carolina’s statute states that each
local school district must include instruction that:
[t]eaches about sexually transmitted diseases. Instruction shall include how
sexually transmitted diseases are and are not transmitted, the effectiveness
and safety of all federal Food and Drug Administration (FDA)-approved
methods of reducing the risk of contracting sexually transmitted diseases,
and information on local resources for testing and medical care for sexually
transmitted diseases. Instruction shall include the rates of infection among
pre-teen and teens of each known sexually transmitted disease and the
effects of contracting each sexually transmitted disease.264
If, like North Carolina, a jurisdiction requires inclusion of all FDA-approved STI
prevention methods, advocates working at the state level can play a role in ensuring
that Truvada as PrEP, which is FDA-approved for HIV prevention, is included as a risk
reduction strategy in curricula throughout the jurisdiction.265
Even in jurisdictions that do not mandate any STI instruction in sex education curricula,
state and local advocates should play a role in encouraging state agencies and local school
boards to require inclusion of information on Truvada as PrEP, specifically, or information
about the existence of pharmacological HIV prevention, generally. This may be more
feasible in those school districts adopting the comprehensive sex education model than
in those districts adopting the abstinence-only model. To be sure, convincing schools to
include education about pharmacological HIV prevention is likely easier when the school
already includes a range of STI prevention methods and is not committed to the abstinence
ideology.266

264

N.C. Gen. Stat. § 115C-81(4a)(a) (West 2015) (emphasis added).

265 Although Truvada as PrEP is only FDA-approved for use in adults eighteen years of age and older, this
is not a reason to exclude it from curricula entirely, especially since some secondary school students may be
eighteen years old.
266 In those communities in which schools teach abstinence as the sole means of STI prevention, local clinics
and advocates play an especially important role in ensuring the dissemination of accurate information about
PrEP to at-risk youth outside the school context, as these are the youth who are likely the most under-informed
about HIV prevention.
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Local and state advocacy related to inclusion of PrEP in sexual education curricula,
however, will likely need to be supported by national advocacy on the issue, as state and
local politics are notoriously contentious in matters of in-school sexual education programs.
B. National Advocacy: PrEP in PREP
In addition to seeking inclusion of PrEP in sex education curricula through state and
local action, advocates may also seek inclusion of PrEP in sex education curricula through
federal action. In passing the Patient Protection and Affordable Care Act on March 23,
2010,267 and amending Title V of the Social Security Act,268 Congress created the Personal
Responsibility Education Program (or PREP, not to be confused with PrEP),269 administered
by the Family and Youth Services Bureau (FYSB), a division of HHS. Through PREP,
the FYSB awards grants to states to ensure youth education about “both abstinence and
contraception to prevent pregnancy and sexually transmitted infections,”270 which includes
HIV/AIDS.271 Those states receiving PREP funding are required to provide youth with
medically accurate information,272 and programs must “replicate evidence-base[d] effective
programs or substantially incorporate elements of effective programs.”273 Sample programs
are included in funding opportunity announcements (FOAs),274 and future FOAs could
include programs that include education on pharmacological HIV prevention methods
in addition to traditional biomedical prevention methods such as condoms. However,
pursuant to the Secretary’s broad discretion to ensure compliance275 and to mandate

267 Patient Protection and Affordable Care Act of 2010, Pub. L. No. 111-148, 124 Stat. 119 (codified as
amended in scattered sections of 42 U.S.C.).
268

Id. at § 2953 (amending Title V of Social Security Act).

269

42 U.S.C. § 713 (2012).

270 U.S Dep’t of Health & Hum. Servs., State Personal Responsibility Education Program Fact Sheet
(2015), http://www.acf.hhs.gov/programs/fysb/resource/prep-fact-sheet [http://perma.cc/5RSM-67JV].
271

42 U.S.C. § 713(b)(2)(A)(i).

272

42 U.S.C. § 713(b)(2)(B)(i).

273 U.S. Dep’t of Health and Hum. Servs., State Personal Responsibility Education Program (PREP),
Orientation Webinar 24, 44 (Nov. 17, 2010), http://www.acf.hhs.gov/sites/default/files/fysb/prep-webinarslides-101117.pdf [http://perma.cc/ZU8J-K633].
274

Id. at 24.

275

42 U.S.C. § 713(a)(4)(C) (requiring “rigorous federal evaluation” of state programs funded by the Act).
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inclusion of information in grant applications not specifically required by the ACA,276 it
is possible that the Secretary could require states to establish goals for reaching youth at
risk of HIV infection. Further, to ensure the accuracy and completeness of programs, HHS
could mandate or encourage inclusion of a range of HIV prevention methods in addition
to condoms. This could be achieved through regulation, in FOAs, or during annual grantee
meetings. This is also consistent with the Secretary’s power to ensure that grantees develop
programs that are “medically accurate and complete.”277 After all, given the emergence of
PrEP, a medically effective and FDA-approved HIV prevention method, comprehensive
sex education programs that solely teach abstinence and condom usage as effective HIV
prevention methods are incomplete.
The potential impact of this approach would be felt nationally. By way of example, in
fiscal year 2010, forty-six states and the District of Columbia received federal funding for
PREP sex education.278 Thus, targeting PREP as a means of ensuring that sex education
programs include information about PrEP among the range of HIV prevention methods
would guarantee that at-risk youth nationwide have a basic familiarity with PrEP, ensure its
legitimacy as an effective means of HIV prevention, and help eliminate stigma surrounding
it. This, in turn, could help foster substantive, honest discussions between at-risk youth and
their healthcare providers about which HIV prevention method would work best for them.
Conclusion
Our current understanding of adolescent risk-taking and reward sensitivity makes
developing strategies that shelter at-risk youth from the negative consequences of their
alacrity an essential public health goal. While Truvada as PrEP is not a “magic pill” to protect
against infection, it is a necessary new tool for HIV prevention among youth because of
its unique, risk-shielding nature. Yet operationalizing PrEP for youth, and eventually other
pharmacological HIV prevention modalities, involves compound challenges. The gravest
of these challenges concerning PrEP for youth is ensuring confidential access without
parental involvement. In the context of HIV-related healthcare, fear that a parent will find
out about a minor’s appeal for advice about protection “constitutes a significant barrier
to reaching [them].”279 Permitting minors to access PrEP without parental involvement
276

42 U.S.C. § 713(a)(1)(C).

277

42 U.S.C. § 713(b)(2)(B)(ii).

278

Lashof-Sullivan, supra note 260, at 293, App. B (listing states that received federal funding for PREP).

279

See New York v. Schweiker, 557 F. Supp. 354, 360 (S.D.N.Y 1983) (citing S. Rep. No. 95-102, at 26
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is consistent with federal and state legislative acknowledgments of this reality in laws
that lower the age of consent in matters of sexual healthcare such as STI diagnosis and
treatment.
The viability of PrEP as a prevention option for at-risk youth is also dependent upon its
acceptability. The addition of PrEP to school sex education curricula, achieved through state
and federal action, helps make it an acceptable HIV prevention option to youth populations.
If PrEP is both accessible and acceptable to at-risk youth, providers would have greater
flexibility to meet the highly individual sexual healthcare needs of their adolescent patients,
and youth may be more receptive to a provider’s presentation of the option. Furthermore,
recognizing that they have freedom of choice and armed with an understanding of the full
range of HIV prevention options available, youths would also have a greater incentive to
collaborate with their doctors in developing prevention regimens that work for them. This
opportunity for adult-youth engagement about risk behavior means that PrEP could be a
remarkable vehicle to learn about—perhaps even to shape—the adolescent mind.
One critical step toward achieving this end involves incentivizing at-risk youth to
seek care by safeguarding the confidentiality of that care. Advocates, lawmakers, and
policymakers should conduct reviews of minor consent and parental notification statutes
using frameworks such as those herein to pinpoint: (1) any state-level opportunities
to furnish PrEP without parental involvement; (2) any gaps in existing statutes that
disadvantage certain at-risk youth; and (3) any justifications for federal action to help
universalize confidential sexual healthcare for minors. This Article pinpoints some of these
opportunities, gaps, and justifications. Achieving active engagement between adolescents
and their providers also involves empowering youth to begin these conversations by giving
them complete information in sex education about the full range of available HIV prevention
methods. State and federal governments must take a hands-on role in guaranteeing the
completeness of these programs. Knowledge gained therefrom will embolden our youth to
take charge of their health, to safeguard their future, and to protect each other.

(1977), as reprinted in 1977 U.S.C.C.A.N. 549; S. Rep. No. 95-822, at 31 (1978)).
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Appendix: STI Consent Statutes
(U.S. Jurisdictions Permitting Minors to Consent to Certain STI Services)

Table 1. Narrow: Prevention and Treatment
Jurisdiction
Alaska

Citation
Alaska Stat.
§ 25.20.025 (2015)

Colorado

Colo. Rev. Stat.
§ 25-4-402 (2015)

“Any physician . . . with the consent of the minor patient,
may make a diagnostic examination for sexually transmitted
infection and may prescribe for and treat the minor patient
for sexually transmitted infection without the consent of or
notification to the parent or guardian . . . .”

Connecticut

Conn. Gen. Stat.
§ 19a-216 (2015)

“Any municipal health department, state institution or
facility, licensed physician or public or private hospital
or clinic, may examine or provide treatment for venereal
disease for a minor . . . .”

Fla. Stat. § 384.3
(2015)
Ky. Rev. Stat. Ann. §
214.185 (West 2015)

A physician “may examine and provide treatment for
sexually transmissible diseases to any minor . . . .”

Florida
Kentucky

Relevant Text
A minor may consent to “diagnosis, prevention, or
treatment of pregnancy, and for diagnosis and treatment of
venereal disease[.]”

“Any physician . . . with the consent of [the] minor may
advise, prescribe for, and treat such minor regarding
venereal disease[.]”

Me. Stat. tit. 32, §§
2595, 3292; Me. Stat.
tit. 22, § 1823 (2015)

“An individual licensed under this chapter who renders
medical care to a minor for treatment of venereal disease . .
. is under no obligation to obtain the consent of the minor’s
parent . . . .”
A minor has capacity to consent to “[t]reatment for or
advice about venereal disease[.]”

Minnesota

Md. Code Ann.,
Health-Gen. § 20102(c)(3) (West 2015)
Minn. Stat. §
144.343(1) (2015)

Mississippi

Miss. Code Ann. § 4141-13 (2015)

“Any physician. . . or any nurse practitioner, who, in the
exercise of due care, renders medical care to a minor for
treatment of a venereal disease is under no obligation to
obtain the consent of a parent or guardian . . . .”

Mo. Rev. Stat. §
431.061(4) (2015)

“Any minor [may consent] for himself in case of . . .
[v]enereal disease[.]”

Maine

Maryland

Missouri

“Any minor may give effective consent for medical, mental
and other health services to determine the presence of or to
treat . . . venereal disease . . . .”
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N.H. Rev. Stat. Ann. §
141-C:18 (II) (2015)

“Any minor 14 years of age or older may voluntarily submit
himself to medical diagnosis and treatment for a sexually
transmitted disease and a licensed physician may diagnose,
treat or prescribe for the treatment of a sexually transmitted
disease in a minor 14 years of age or older, without the
knowledge or consent of the parent or legal guardian . . . .”

New Mexico

N.M. Stat. Ann. § 241-9 (2015)

“Any person regardless of age has the capacity to consent
to an examination and treatment by a licensed physician for
any sexually transmitted disease[.]”

North Dakota

N.D. Cent. Code
§ 14-10-17 (2015)

“Any person of the age of fourteen years or older may
contract for and receive examination, care, or treatment
for sexually transmitted disease . . . without permission,
authority, or consent of a parent or guardian[.]” (emphasis
added)
“[A] minor may give consent for the diagnosis or treatment
of any venereal disease by a licensed physician[.]”

Pennsylvania

Ohio Rev. Code Ann. §
3709.241 (West 2015)
35 Pa. Cons. Stat
§ 10103 (2015)

Rhode Island

23 R.I. Gen. Laws
§ 23-6.3-3(l) (2015)

“[I]ndividuals under eighteen (18) years of age may give
legal consent for testing, examination, and/or treatment for
any reportable communicable disease, including HIV[.]”

Tennessee

Tenn. Code Ann.
§ 68‐10‐104 (2015)

“[A]ny physician may examine, diagnose and treat minors
infected with STDs without the knowledge or consent of the
parents of the minors . . . .”

Tex. Fam. Code Ann.
§ 32.003(a)(3) (West
2015)
Vt. Stat. Ann. tit. 18, §
4226 (a) (2015)

A minor may “consent[] to the diagnosis and treatment of
an infectious, contagious, or communicable disease . . . .”

New
Hampshire

Ohio

Texas

Vermont

“Any minor may give effective consent for medical and
health services to determine the presence of or to treat . . .
venereal disease” and other reportable diseases.

“If a minor 12 years of age or older is suspected . . . [of
having] venereal disease . . . [and such is] verified by
a licensed physician, the minor may give . . . his or her
consent to medical treatment . . . .”

West Virginia

Va. Code Ann.
§ 54.1-2969(E)(1)
(2015)
W. Va. Code
§ 16-4-10 (2015)

Wisconsin

Wis. Stat. §
252.11(1m) (2015)

“A physician may treat a minor infected with a sexually
transmitted disease or examine and diagnose a minor for the
presence of such a disease without obtaining the consent of
the minor’s parents or guardian[.]”

Wyoming

Wyo. Stat. Ann.
§ 35‐4‐131(a) (2015)

“Persons under eighteen (18) years of age may give legal
consent for examination and treatment for any sexually
transmitted disease infection[.]”

Virginia

Consent of minor is valid for “[m]edical or health services
needed to determine the presence of or to treat venereal
disease[.]”
“[A]ny licensed physician may examine, diagnose, or treat
any minor with his or her consent for any venereal disease
without the knowledge or consent of the minor’s parent or
guardian[.]”
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Table 2. Broader: Care or Prescription
Jurisdiction

Citation

Relevant Text

Alabama

Ala. Code §§ 22-8-6,
22-11A-19 (2015)

“[A] minor 12 years of age or older who may have come into
contact with any sexually transmitted disease as designated by
the State Board of Health may give consent to the furnishing
of medical care related to the diagnosis or treatment of such
disease.”

Arizona

Ariz. Rev. Stat. Ann.
§ 44.-132.01 (2015)

“[A] minor who may have contracted a venereal disease may
give consent to the furnishing of hospital or medical care
related to the diagnosis or treatment of such disease . . . .”

Arkansas

Ark. Code Ann. § 2016-508(a)(1) (2015)

“[A] minor who believes himself or herself to have a
sexually transmitted disease consents to the provision of
medical care . . . .”

Georgia

Ga. Code Ann. § 3117-7 (2015)

“The consent to the provision of medical or surgical care or
services . . . when such consent is given by a minor who is or
professes to be afflicted with a venereal disease, shall be as
valid and binding as if the minor had achieved his majority,
provided that any such treatment shall involve procedures and
therapy related to conditions or illnesses arising out of the
venereal disease which gave rise to the consent . . . .”

Hawaii

Haw. Rev. Stat. §
577A-2 (2015)

“The consent to the provision of medical care and services
. . . when executed by . . . a minor who is or professes to be
afflicted with a venereal disease . . . shall be valid and binding
as if the minor had achieved his or her majority . . . .”

Idaho

Idaho Code Ann. §
39-3801 (2015)

“[A] minor fourteen (14) years of age or older who may have
come into contact with [an STI] may give consent to the
furnishing of . . . care related to the diagnosis or treatment of
such disease.”

Illinois

410 Ill. Comp. Stat.
§ 210/4 (2015)

“[A] minor 12 years of age or older who may have come into
contact with any sexually transmitted disease . . . may give
consent to the furnishing of medical care or counseling related
to the diagnosis or treatment of the disease.”

Indiana

Ind. Code § 16-36-13(d) (2015)

“An individual who has, suspects that the individual has, or has
been exposed to a venereal disease is competent to give consent
for medical or hospital care or treatment of the individual.”

Kansas

Kan. Stat. Ann. §
65-2892 (2015)

“Any physician, upon consultation by any person under
eighteen (18) years of age as a patient, may, with the consent
of such person who is hereby granted the right of giving such
consent, make a diagnostic examination for venereal disease
and prescribe for and treat such person for venereal disease
including prophylactic treatment for exposure to venereal
disease whenever such person is suspected of having a venereal
disease or contact with anyone having a venereal disease.”
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Louisiana

La. Rev. Stat. Ann. §
40:1121.8(A) (2015)

“Consent to the provision of medical or surgical care or services
by a hospital or public clinic, or to the performance of medical
or surgical care or services by a physician, licensed to practice
medicine in this state, when executed by a minor who is or
believes himself to be afflicted with a venereal disease, shall
be valid and binding as if the minor had achieved his majority.
Any such consent shall not be subject to a later disaffirmance
by reason of his minority.”

Massachusetts

Mass. Gen. Laws ch.
112, § 12F(vi) (2015)

A minor can consent if “he reasonably believes himself to be
suffering from or to have come in contact with any [reportable]
disease . . . ; provided, however, that such minor may only
consent to care which relates to the diagnosis or treatment of
such disease.”

Michigan

Mich. Comp. Laws §
333.5127(1) (2015)

“[T]he consent to the provision of medical or surgical care,
treatment, or services by a hospital, clinic, or physician that is
executed by a minor who is or professes to be infected with a
venereal disease or HIV is valid and binding as if the minor had
achieved the age of majority.”

Nebraska

Neb. Rev. Stat. §
71‐504 (2015)

Physician may “make or cause to be made a diagnostic
examination for sexually transmitted diseases and prescribe
for and treat such person for sexually transmitted diseases
including prophylactic treatment for exposure to sexually
transmitted diseases whenever such person is suspected of
having a sexually transmitted disease or contact with anyone
having a sexually transmitted disease.”

Nevada

Nev. Rev. Stat. §§
441A.310, 129.060
(2015)

“[T]he consent of the parent, parents or legal guardian of a
minor is not necessary in order to authorize a local or state
health officer, licensed physician or clinic to examine or treat,
or both, any minor who is suspected of being infected or is
found to be infected with any sexually transmitted disease.”

New Jersey

N.J. Stat. Ann. §
9:17A-4 (West 2015)

“The consent to [care], when executed by a minor who is or
believes that he may be afflicted with a venereal disease, or
who is at least 13 years of age and is or believes that he may
be infected with [HIV] or have [AIDS] . . . shall be valid and
binding . . . .” (emphasis added).

New York

N.Y. Pub. Health
Law § 2305(2)
(McKinney 2015)

“A licensed physician, or in a hospital, a staff physician,
may diagnose, treat or prescribe for a person under the age
of twenty-one years without the consent or knowledge of
the parents or guardian of said person, where such person
is infected with a sexually transmitted disease, or has been
exposed to infection with a sexually transmitted disease.”

Oregon

Or. Rev. Stat.
§109.610 (2015)

“[A] minor who may have come into contact with any venereal
disease, including HIV, may give consent to the furnishing of
hospital, medical or surgical care related to the diagnosis or
treatment of such disease . . . .”
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South Dakota

S.D. Codified Laws §
34-23-16 (2015)

“Any licensed physician, upon consultation by any minor as
a patient, may, with the consent of such person who is hereby
granted the right of giving such consent, make a diagnostic
examination for venereal disease and prescribe for and treat
such person for venereal disease including prophylactic
treatment for exposure to venereal disease whenever such
person is suspected of having a venereal disease or contact with
anyone having a venereal disease. Any such consent shall not
be subject to later disaffirmance by reason of minority.”

Utah

Utah Code Ann. §
26‐6‐18(1)-(3) (West
2015)

Consent to care of minor “who is or professes to be afflicted
with” an STI is valid even if “professed suspicions” are
unsubstantiated.

Washington

Wash. Rev. Code §
70.24.110 (2015)

“A minor fourteen years of age or older who may have come
in contact with any sexually transmitted disease or suspected
sexually transmitted disease may give consent to the furnishing
of hospital, medical and surgical care related to the diagnosis or
treatment of such disease.”
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Table 3. Broadest: Adding Prevention
Jurisdiction

Citation

Relevant Text

California

Cal. Fam. Code §
6926(a)-(b) (West 2015)

“A minor who is 12 years of age or older may consent to
medical care related to the prevention of a sexually transmitted
disease[.]”

Delaware

Del. Code Ann. tit. 13,
§ 710(a)-(b) (2015)

“A minor 12 years of age or over who professes to be . . .
afflicted with contagious, infectious or communicable diseases
. . . may give written consent, except to abortion, to any
licensed physician, hospital or public clinic for any diagnostic,
preventive, lawful therapeutic procedures, medical or surgical
care and treatment, . . . by any physician licensed for the
practice of medicine or surgery or osteopathic medicine or
surgery in this State and by any hospital or public clinic, their
qualified employees or agents while acting within the scope of
their employment[.]”

District of
Columbia

D.C. Mun. Regs. tit. 22,
§ B600.7 (2015)

“A minor of any age may consent to health services which he
or she requests for the prevention, diagnosis, or treatment of
the following medical situations: . . . A mental or emotional
condition and sexually transmitted disease[.]”

Iowa Code § 139A.35
(2015)

“A minor shall have the legal capacity to act and give consent
to provision of medical care or services to the minor for the
prevention, diagnosis, or treatment of a sexually transmitted
disease or infection by a hospital, clinic, or health care
provider[.]”

Montana

Mont. Code Ann. § 411-402(2)-(c) (2015)

“[A] minor who professes or is found to be pregnant or
afflicted with any reportable communicable disease, including
a sexually transmitted disease, or drug and substance abuse,
including alcohol. This self-consent applies only to the
prevention, diagnosis, and treatment of those conditions
specified in this subsection[.]”

North
Carolina

N.C. Gen. Stat. § 9021.5(a) (2015)

“Any minor may give effective consent to a physician licensed
to practice medicine in North Carolina for medical health
services for the prevention, diagnosis and treatment of . . .
venereal disease and other [reportable] diseases . . . .”

Oklahoma

Okla. Stat. tit. 63,
§§ 2601, 2602 (A)(3)
(2015)

“Any minor who is or has been pregnant, afflicted with any
reportable communicable disease, drug and substance abuse
or abusive use of alcohol; provided, however, that such selfconsent only applies to the prevention, diagnosis and treatment
of those conditions specified in this section [2602.]”

Iowa

